<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Rep</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Rep</journal-id><journal-id journal-id-type="publisher-id">pediatrrep</journal-id><journal-title-group><journal-title>Pediatric Reports</journal-title></journal-title-group><issn pub-type="ppub">2036-749X</issn><issn pub-type="epub">2036-7503</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407582</article-id><article-id pub-id-type="pmc">PMC12101243</article-id>
<article-id pub-id-type="doi">10.3390/pediatric17030057</article-id><article-id pub-id-type="publisher-id">pediatrrep-17-00057</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Functional and Structural Alterations in Pediatric Multiple Sclerosis: A Systematic Review and a Preliminary Activation Likelihood Estimation Functional Magnetic Resonance Imaging Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2702-8789</contrib-id><name><surname>Cera</surname><given-names>Nicoletta</given-names></name><xref rid="af1-pediatrrep-17-00057" ref-type="aff">1</xref><xref rid="af2-pediatrrep-17-00057" ref-type="aff">2</xref><xref rid="c1-pediatrrep-17-00057" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-7659-686X</contrib-id><name><surname>Pinto</surname><given-names>Joana</given-names></name><xref rid="af1-pediatrrep-17-00057" ref-type="aff">1</xref><xref rid="af3-pediatrrep-17-00057" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Faustino</surname><given-names>Ricardo</given-names></name><xref rid="af2-pediatrrep-17-00057" ref-type="aff">2</xref><xref rid="af4-pediatrrep-17-00057" ref-type="aff">4</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Carotenuto</surname><given-names>Marco</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pediatrrep-17-00057"><label>1</label>Faculty of Psychology and Education Sciences, University of Porto, 4200-135 Porto, Portugal; <email>up201707095@up.pt</email></aff><aff id="af2-pediatrrep-17-00057"><label>2</label>Cross I&#x00026;D Lisbon Research Center, Escola Superior de Sa&#x000fa;de da Cruz Vermelha Portuguesa, 1300-125 Lisbon, Portugal</aff><aff id="af3-pediatrrep-17-00057"><label>3</label>Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal</aff><aff id="af4-pediatrrep-17-00057"><label>4</label>Institute of Biophysics and Biomedical Engineering, Faculty of Science, University of Lisbon, 1749-016 Lisbon, Portugal</aff><author-notes><corresp id="c1-pediatrrep-17-00057"><label>*</label>Correspondence: <email>cera.nicoletta@fpce.up.pt</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>17</volume><issue>3</issue><elocation-id>57</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>07</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>08</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objectives: Pediatric multiple sclerosis (MS) is a rare and complex neuroinflammatory disease characterized by demyelination and neurological dysfunction in individuals under 18 years of age. This systematic review and activation likelihood estimation (ALE) meta-analysis aimed to synthesize the existing literature on functional and structural brain alterations in pediatric MS patients. Methods: Following the PRISMA guidelines, we analyzed 21 studies involving 917 pediatric MS patients and 320 healthy controls, assessing brain structure and function using MRI and fMRI techniques. Results: The results reveal consistent alterations in brain regions critical for cognitive and motor functions, including reduced brain volume, increased lesion load, and disrupted functional connectivity, particularly in the thalamus, cerebellum, and hippocampus. The ALE meta-analysis identified significant activation clusters in the dorsal anterior cingulate cortex, angular gyrus, and superior parietal lobes, regions associated with cognition, attention, and working memory. Conclusions: These findings suggest that pediatric MS uniquely affects brain development, contributing to cognitive impairments that differ from those observed in adult MS. Our study underscores the importance of early diagnosis and tailored therapeutic interventions to mitigate neurodevelopmental disruptions and improve long-term outcomes in pediatric MS patients.</p></abstract><kwd-group><kwd>pediatric multiple sclerosis</kwd><kwd>functional MRI</kwd><kwd>structural brain alterations</kwd><kwd>activation likelihood estimation (ALE)</kwd><kwd>cognitive impairment</kwd><kwd>brain connectivity</kwd><kwd>neurodevelopment</kwd><kwd>thalamic atrophy</kwd><kwd>cerebellar lesions</kwd><kwd>white matter abnormalities</kwd></kwd-group><funding-group><award-group><funding-source>the Portuguese Foundation for Science and Technology</funding-source><award-id>FCT-2024.01355.BD</award-id></award-group><funding-statement>J.P. is supported by a grant from the Portuguese Foundation for Science and Technology (FCT-2024.01355.BD).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pediatrrep-17-00057"><title>1. Introduction</title><p>Pediatric multiple sclerosis (MS) is a complex and challenging neuroinflammatory disorder characterized by demyelination and subsequent neurological dysfunction in individuals under the age of 18. Pediatric MS is a rare disease with an incidence of 0.13&#x02013;0.6 cases per 100,000 children per year [<xref rid="B1-pediatrrep-17-00057" ref-type="bibr">1</xref>]. Additionally, 2&#x02013;10% of individuals diagnosed with MS experience their first symptoms during childhood [<xref rid="B2-pediatrrep-17-00057" ref-type="bibr">2</xref>]. According to a recent meta-analysis [<xref rid="B3-pediatrrep-17-00057" ref-type="bibr">3</xref>], most epidemiological studies reported a higher prevalence of pediatric MS among high-income countries. Most of these studies were carried out in European and Middle Eastern countries [<xref rid="B3-pediatrrep-17-00057" ref-type="bibr">3</xref>].</p><p>Preadolescent patients presented with multifocal symptoms, whereas adolescent patients showed single-focal symptoms that were more similar to those observed in adults. Among the four subtypes of MS, 95&#x02013;98% of pediatric patients are classified as relapsing&#x02013;remitting, and less than 3% of patients are primarily progressive [<xref rid="B4-pediatrrep-17-00057" ref-type="bibr">4</xref>]. During the last few years, magnetic resonance imaging (MRI) has played a prominent role in the diagnosis and prediction of the clinical course in adults with MS. In adult patients, at the first attack, the spinal cord and asymptomatic infratentorial lesions are associated with the development of clinical disability as assessed by the EDSS [<xref rid="B5-pediatrrep-17-00057" ref-type="bibr">5</xref>]. This type of information is still lacking in the MS pediatric population.</p><p>While recent studies have made significant strides in understanding clinical predictors and treatment responses in pediatric MS patients [<xref rid="B6-pediatrrep-17-00057" ref-type="bibr">6</xref>,<xref rid="B7-pediatrrep-17-00057" ref-type="bibr">7</xref>], a crucial gap remains in comprehensively examining the functional and structural brain alterations specific to this unique patient population. However, only a few longitudinal studies have been carried out to disentangle the clinical course and outcomes in patients who developed MS before the age of 18 years [<xref rid="B8-pediatrrep-17-00057" ref-type="bibr">8</xref>,<xref rid="B9-pediatrrep-17-00057" ref-type="bibr">9</xref>].</p><p>Functional magnetic resonance imaging (fMRI) is a noninvasive technique that is able to investigate the cerebral underpinnings of different cognitive and emotional functions by collecting and studying blood oxygen level-dependent (BOLD) signals [<xref rid="B10-pediatrrep-17-00057" ref-type="bibr">10</xref>]. fMRI allows the depiction of both task-related and spontaneous brain activity. According to a recently published review [<xref rid="B11-pediatrrep-17-00057" ref-type="bibr">11</xref>], BOLD changes in MS adult patients have been widely studied using motor and visual tasks, which highlighted a complex set of cortical and subcortical brain regions. In adult MS patients, 71 task-based and 22 resting-state fMRI studies were identified in 2018 [<xref rid="B12-pediatrrep-17-00057" ref-type="bibr">12</xref>]. Interestingly, most studies have focused on working memory and motor functions, with limited attention given to decision-making. Among the task-based fMRI studies, MS patients with cognitive impairment presented decreased activation of the hippocampal network and no additional activations in the premotor or prefrontal cortex. Resting-state studies, which use different analytical techniques, revealed alterations in the crosstalk among the principal resting-state networks in MS. The default mode network (DMN), one of the principal resting-state networks, was altered in patients with a progressive form of MS. These alterations were more pronounced in patients with cognitive impairment.</p><p>Despite these results in the adult population, less is known about functional brain alterations in pediatric patients with MS.</p><p>This review seeks to address this gap through a systematic review and activation likelihood estimation (ALE) meta-analysis. Our primary focus is synthesizing literature to provide a comprehensive overview of the functional and structural brain changes observed in pediatric MS. By incorporating findings from recent studies, we aim to offer a nuanced understanding of the neural underpinnings of pediatric MS.</p><p>The structural and functional alterations in the developing brain present unique challenges and opportunities for intervention in pediatric MS patients. Our systematic review critically examines the existing evidence and identifies key trends, inconsistencies, and gaps in the literature. Furthermore, the ALE meta-analysis provides a quantitative synthesis of neuroimaging data, offering insights into the spatial convergence of reported brain alterations in pediatric MS patients.</p><p>As we embark on this exploration of the pediatric MS neuroimaging landscape, our goal is to contribute to a deeper understanding of the intricate interplay between clinical manifestations, brain structure, and function. By elucidating these relationships, we hope to pave the way for targeted interventions and personalized treatment strategies that address the specific needs of children and adolescents grappling with this challenging neurological condition.</p></sec><sec id="sec2-pediatrrep-17-00057"><title>2. Materials and Methods</title><p>The present review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the PICO research question strategy protocol (the PROSPERO registration No. is 1023314) [<xref rid="B13-pediatrrep-17-00057" ref-type="bibr">13</xref>]. The flowchart in <xref rid="pediatrrep-17-00057-f001" ref-type="fig">Figure 1</xref> depicts the steps of the selection process [<xref rid="B14-pediatrrep-17-00057" ref-type="bibr">14</xref>].</p><p>Our research question was specifically oriented toward functional and structural neural alterations (O) in MS pediatric patients (P) compared with healthy age-matched controls (C), with different methodological approaches. The present systematic review and meta-analysis were limited to MRI rest or task-based fMRI studies (I).</p><p>We defined the search terms on the basis of the PICO question mentioned above, combined with the Boolean operators &#x0201c;AND&#x0201d; and &#x0201c;OR&#x0201d;, according to the methods used in other previously published systematic reviews [<xref rid="B15-pediatrrep-17-00057" ref-type="bibr">15</xref>,<xref rid="B16-pediatrrep-17-00057" ref-type="bibr">16</xref>].</p><p>We conducted a computer-based literature search following the PICO approach as follows: &#x0201c;pediatrics&#x0201d; [All Fields] OR &#x0201c;pediatrics&#x0201d; [MeSH Terms] OR &#x0201c;pediatrics&#x0201d; [All Fields] OR &#x0201c;pediatric&#x0201d; [All Fields] OR &#x0201c;pediatric&#x0201d; [All Fields]) AND (&#x0201c;multiple sclerosis&#x0201d; [MeSH Terms] OR (&#x0201c;multiple&#x0201d; [All Fields] AND &#x0201c;sclerosis&#x0201d; [All Fields]) OR &#x0201c;multiple sclerosis&#x0201d; [All Fields]) AND (&#x0201c;magnetic resonance imaging&#x0201d; [MeSH Terms] OR (&#x0201c;magnetic&#x0201d; [All Fields] AND &#x0201c;resonance&#x0201d; [All Fields] AND &#x0201c;Imaging&#x0201d; [All Fields]) OR &#x0201c;magnetic resonance imaging&#x0201d; [All Fields] OR &#x0201c;fmri&#x0201d; [All Fields]) AND (&#x0201c;magnetic resonance imaging&#x0201d; [MeSH Terms] OR (&#x0201c;magnetic&#x0201d; [All Fields] AND &#x0201c;resonance&#x0201d; [All Fields] AND &#x0201c;imaging&#x0201d; [All Fields]) OR &#x0201c;magnetic resonance imaging&#x0201d; [All Fields] OR &#x0201c;mri&#x0201d; [All Fields]) AND (&#x0201c;brain&#x0201d; [MeSH Terms] OR &#x0201c;brain&#x0201d; [All Fields] OR &#x0201c;brains&#x0201d; [All Fields] OR &#x0201c;brain s&#x0201d; [All Fields]) AND (&#x0201c;age of onset&#x0201d; [MeSH Terms] OR (&#x0201c;age&#x0201d; [All Fields] AND &#x0201c;onset&#x0201d; [All Fields]) OR &#x0201c;age of onset&#x0201d; [All Fields] OR &#x0201c;onset&#x0201d; [All Fields] OR &#x0201c;onsets&#x0201d; [All Fields] OR &#x0201c;onsetting&#x0201d; [All Fields]). The literature search was conducted to retrieve all the published articles in English from three principal databases: PubMed (MEDLINE), Scopus, and Web of Science.</p><p>The brain imaging studies were identified based on the following inclusion and exclusion criteria described in <xref rid="pediatrrep-17-00057-t001" ref-type="table">Table 1</xref>: (1) whole-brain fMRI or MRI studies; (2) fMRI results presented as coordinate-based (x, y, and z) in MNI or Talairach space; (3) studies that used whole-brain analysis to observe the alteration of intrinsic connectivity patterns in pediatric multiple sclerosis; and (4) studies that assessed gray matter abnormalities. The exclusion criteria were as follows: (1) systematic reviews or meta-analyses; (2) behavioral, genetic, or epidemiological studies; (3) single-case MRI or fMRI studies; (4) other imaging techniques (i.e., PET and SPECT) or EEG; and (5) no coordinates. Moreover, all the studies were checked for the MRI criteria for MS diagnosis [<xref rid="B17-pediatrrep-17-00057" ref-type="bibr">17</xref>].</p><p>All of the included studies were screened to identify additional relevant studies. The narrative, scoping, and systematic reviews and meta-analyses were retrieved and screened to find previous relevant articles in the reference lists. After removing duplicates, the titles and abstracts were assessed to determine if they fulfilled the inclusion and/or exclusion criteria (<xref rid="pediatrrep-17-00057-t001" ref-type="table">Table 1</xref>), and the full texts of potentially relevant studies were retrieved. Then, we read the full texts to confirm their eligibility. The authors independently conducted a literature search, screening, and methodological evaluation. A consensus about the inclusion or exclusion of a study was reached by brainstorming among the authors.</p><p>To assess the quality of the studies included in the present systematic review, we applied the Newcastle&#x02013;Ottawa scale (NOS scale) [<xref rid="B18-pediatrrep-17-00057" ref-type="bibr">18</xref>]. Information was extracted from each included study following the guidelines mentioned above. In particular, we extracted the characteristics of the participants, including the exclusion and inclusion criteria.</p><p>To assess the presence of homogeneity in the fMRI results, an activation likelihood estimation (ALE) meta-analysis was performed using GingerAle 3.02 [<xref rid="B19-pediatrrep-17-00057" ref-type="bibr">19</xref>] (<uri xlink:href="https://www.brainmap.org/ale/">https://www.brainmap.org/ale/</uri>; accessed on 22 April 2024) on the clusters reported in the included studies.</p><p>Ginger Ale generates modeled brain activation maps that combine the probabilities of all foci for each voxel, and the resulting maps are combined to obtain a voxel-wise ALE score. Thus, the ALE scores are the convergence of the study results in brain functional anatomical localization. The obtained scores are then compared with an empirical null distribution representing a causal association across the studies [<xref rid="B20-pediatrrep-17-00057" ref-type="bibr">20</xref>]. When necessary, all the retrieved coordinates were converted into the stereotaxic space of the Montreal Neurological Institute (MNI).</p><p>We used Mango 4.1 [<xref rid="B21-pediatrrep-17-00057" ref-type="bibr">21</xref>] (<uri xlink:href="http://ric.uthscsa.edu/mango/mango.html">http://ric.uthscsa.edu/mango/mango.html</uri>; accessed on 22 April 2024) to visualize the results using a structural MRI T1W MNI template with a 2 &#x000d7; 2 &#x000d7; 2 mm resolution (<uri xlink:href="https://www.brainmap.org/ale/">https://www.brainmap.org/ale/</uri>; accessed on 22 April 2024).</p><p>Therefore, after the resulting ALE maps were calculated, a series of regions of interest (ROIs), in correspondence with the significant clusters found, were delineated to perform a behavioral analysis, and the behavioral analysis plugin was included in Mango v.2.6 (<uri xlink:href="http://ric.uthscsa.edu/mango/plugin_behavioralanalysis.html">http://ric.uthscsa.edu/mango/plugin_behavioralanalysis.html</uri>; accessed on 22 April 2024). Behavioral analysis is presented for BrainMap&#x02019;s five behavioral domains (action, cognition, emotion, interoception, and perception) and sixty subdomains. Only z-scores &#x02265; 3.0 are considered significant (<italic toggle="yes">p</italic> &#x02264; 0.05, Bonferroni corrected) [<xref rid="B22-pediatrrep-17-00057" ref-type="bibr">22</xref>]. This analysis was carried out to identify the domains affected by MS in children.</p></sec><sec sec-type="results" id="sec3-pediatrrep-17-00057"><title>3. Results</title><sec id="sec3dot1-pediatrrep-17-00057"><title>3.1. Characteristics of the Included Studies</title><p>After the selection process, twenty-one studies were included in the present systematic review, as reported in the flowchart depicted in <xref rid="pediatrrep-17-00057-f001" ref-type="fig">Figure 1</xref> and <xref rid="pediatrrep-17-00057-t002" ref-type="table">Table 2</xref> [<xref rid="B23-pediatrrep-17-00057" ref-type="bibr">23</xref>,<xref rid="B24-pediatrrep-17-00057" ref-type="bibr">24</xref>,<xref rid="B25-pediatrrep-17-00057" ref-type="bibr">25</xref>,<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>,<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>,<xref rid="B28-pediatrrep-17-00057" ref-type="bibr">28</xref>,<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>,<xref rid="B30-pediatrrep-17-00057" ref-type="bibr">30</xref>,<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>,<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>,<xref rid="B33-pediatrrep-17-00057" ref-type="bibr">33</xref>,<xref rid="B34-pediatrrep-17-00057" ref-type="bibr">34</xref>,<xref rid="B35-pediatrrep-17-00057" ref-type="bibr">35</xref>,<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>,<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>,<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>,<xref rid="B39-pediatrrep-17-00057" ref-type="bibr">39</xref>,<xref rid="B40-pediatrrep-17-00057" ref-type="bibr">40</xref>,<xref rid="B41-pediatrrep-17-00057" ref-type="bibr">41</xref>,<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>,<xref rid="B43-pediatrrep-17-00057" ref-type="bibr">43</xref>]. <xref rid="pediatrrep-17-00057-t003" ref-type="table">Table 3</xref> shows the characteristics of the included studies. All the studies were published between 2009 and 2024, and they were carried out in Europe (n = 15; 71.4%) and Canada (n = 5; 23.8%), with only one carried out in the USA (4.7%). A total of 1237 (817 girls) pediatric subjects participated in the selected studies, with 917 patients with MS and 320 healthy age-matched controls, as reported in the methods of each published article. Among the patients, 595 were girls (64.8%). The mean age of the patients ranged between 11.1 and 16.8 years. Similarly, the mean age of the healthy controls was between 12.2 and 15.5 years. The global sample can be considered principally composed of adolescents.</p><p>Most of the studies (n = 13; 61.9%) investigated brain structural changes following MS in children. Eight (38%) were fMRI case&#x02013;control and case&#x02013;report studies. Only two (12.5%) included studies were diffusion tensor imaging (DTI) studies.</p><p>All the studies reported neurological assessments performed using the expanded disability status scale (EDSS), and all the patients were classified as relapsing&#x02013;remitting (RR).</p></sec><sec id="sec3dot2-pediatrrep-17-00057"><title>3.2. Neuropsychological Results</title><p>Among the included studies, eleven (52.3%) reported neuropsychological assessments of MS patients. Most of the studies applied the brief neuropsychological battery for children [<xref rid="B44-pediatrrep-17-00057" ref-type="bibr">44</xref>], which was designed to study the presence of cognitive impairment in children and adolescents affected by multiple sclerosis. However, despite these findings, the studies also investigated the domains and subdomains <xref rid="app1-pediatrrep-17-00057" ref-type="app">Appendix A</xref>). The studies focused their attention on the assessment of working memory, sustained attention, abstract reasoning, and language. Three studies reported that it was possible to identify patients with cognitive impairments [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>,<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>,<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>]. De Meo et al. [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>] reported that among patients classified as cognitively impaired, none presented specific alterations in attention. Similarly, Fuentes et al. [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>], Hubacher et al. [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>], and Margoni et al. [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>] reported no working memory alterations when patients and controls were compared or when patients&#x02019; results were compared with normative data. Conversely, Rocca et al. [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>] found that the cognitive domains most frequently involved were spatial and verbal memory, language, and attention, confirming the results of other studies [<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>].</p><p>Interestingly, Hubacher et al. [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>] reported a case series study in which cognitive training was applied using a computerized training tool, BrainStim [<xref rid="B45-pediatrrep-17-00057" ref-type="bibr">45</xref>,<xref rid="B46-pediatrrep-17-00057" ref-type="bibr">46</xref>]. This training was based on Baddeley&#x02019;s working memory model [<xref rid="B47-pediatrrep-17-00057" ref-type="bibr">47</xref>], which consists of three different modules that target both verbal and visual&#x02013;spatial aspects. After the training, two out of five participants showed performance improvement, and the remaining participants showed no detrimental performance.</p><p>Among these, Green et al. [<xref rid="B40-pediatrrep-17-00057" ref-type="bibr">40</xref>] assessed communication skills, including verbal and nonverbal skills and verbal memory, finding that patients had poorer skills than age-matched controls.</p></sec><sec id="sec3dot3-pediatrrep-17-00057"><title>3.3. Structural Imaging Results</title><p><xref rid="pediatrrep-17-00057-t003" ref-type="table">Table 3</xref> summarizes the principal findings as well as the methods reported in the retrieved articles. Most of the included studies (n = 11; 68.7%) described MRI structural alterations found in MS patients. Similarly, the adult population was excluded or used as a group for comparison in some of the included studies [<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>]. Data concerning the adult patient group were not taken into consideration in the present review.</p><p>Studies investigating functional brain imaging alterations were also screened to find structural MRI data. The principal interest observed in the included structural studies was to assess the presence, frequency, and topography of gray and white matter (GM and WM) lesions. Despite the different topographies and frequencies observed in each study, all of them agreed that patients presented a significantly lower whole-brain volume, increased ventricular volume, and a greater number of lesions in both the GM and WM than in healthy controls. GM alterations were investigated by assessing the hypointensities in T1 images, whereas WM alterations were studied using the hyperintensities in T2 images. Interestingly, Margoni et al. [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>] reported that the number of lesions was greater in images obtained with phase-sensitive inversion recovery (PSIR) than in those obtained with double inversion recovery (DIR) sequences from a 3T MR scanner. With an interest in WM, several studies have applied DTI and reported a reduction in fractional anisotropy (FA) and an increase in mean diffusivity (MD). More specifically, alterations were observed in correspondence with the median line, involving the precuneus, posterior cingulate cortex, corpus callosum, bilateral superior longitudinal fasciculus, and optic pathway [<xref rid="B23-pediatrrep-17-00057" ref-type="bibr">23</xref>,<xref rid="B30-pediatrrep-17-00057" ref-type="bibr">30</xref>]. More specifically, structures such as the cerebellum, hippocampus, caudate nucleus, and thalamus have been found to be altered in MS patients.</p><p>Indeed, according to Margoni et al. [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>], 93% of patients presented with GM lesions in the cerebellum, with a greater frequency in the posterior cerebellar lobe. Similarly, Weier et al. [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>] reported that the volume of the cerebellum was significantly reduced in the pediatric MS group. In particular, the cerebellar volume, together with the infratentorial lesion volume, accounted for the extra variance in the WASI vocabulary and the SDTM (Symbol Digit Modality Test) [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>]. Lesions in the cerebellum are more common in pediatric MS patients than in adult MS patients [<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>]. Cerebellar lesions, as well as cervical cord and optic nerve lesions, can also be considered relevant predictors of the relapse rate at baseline [<xref rid="B35-pediatrrep-17-00057" ref-type="bibr">35</xref>]. The presence of alterations in the hippocampus was investigated in two different studies. Fuentes et al. [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>] were interested in finding cerebral correlates of memory impairment observed in MS. They observed specific alterations in the amygdala and thalamus but not in the hippocampus. However, the hippocampus volume was found to be correlated with word-listening learning. As shown by Rocca et al. [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>], MS patients exhibit atrophy in the bilateral cornu ammonis, subiculum, and dentate gyrus and hypertrophy of subcomponents of the dentate gyrus. However, regional alterations in the hippocampus are associated with the level of attention and language, as assessed by neuropsychological tests. These results partially confirm those previously obtained by Fuentes et al. [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>].</p><p>Kerbrat and colleagues [<xref rid="B39-pediatrrep-17-00057" ref-type="bibr">39</xref>] reported a reduction in the global head volume and a reduced thalamic volume following the pediatric onset of MS. However, by combining several MRI techniques and analyzing the thalamus using a laminar approach, De Meo et al. [<xref rid="B43-pediatrrep-17-00057" ref-type="bibr">43</xref>] reported that MS patients tended toward a reduction in the thalamus compared with healthy controls. Moreover, they reported that 12 patients presented with thalamic atrophy, with increased levels of fractional anisotropy (FA), T1/T2 ratios, and mean diffusivity (MD) in regions close to the cerebrospinal fluid.</p><p>Despite these findings, some studies have investigated cerebral alterations in the course of the disease with one or more follow-ups. Ceccarelli et al. [<xref rid="B33-pediatrrep-17-00057" ref-type="bibr">33</xref>], comparing CIS and MS patients, found that the intensity of T2 images of the caudate nucleus remains stable after one year. After two years, in patients receiving steroid therapy, a reduction in WM and total brain volume and an increase in ventricular volume were observed [<xref rid="B34-pediatrrep-17-00057" ref-type="bibr">34</xref>].</p><p>A comparison between cognitively impaired and cognitively preserved patients revealed that, compared with cognitively preserved patients, cognitively impaired MS patients have a greater occurrence of T2 lesions [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>]. However, the hippocampal volume was not found to be affected by cognitive impairment [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>].</p></sec><sec id="sec3dot4-pediatrrep-17-00057"><title>3.4. Functional MRI Studies and ALE Meta-Analysis Results</title><p>Among the selected studies, eight (n = 8; 38%) investigated brain functional alterations related to MS in children and adolescents. Four (n = 4; 19%) of these used a resting state, while two (9.5%) used an attentional and a working memory task, and the other two (9.5%) used a finger-tapping motor task. However, one (4.76%) of the studies was a case series study without reporting the resulting coordinates and describing the results case by case [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>].</p><p>Despite the presence of only a few fMRI-published studies, they attempt to disentangle the principal features observed in pediatric MS. A detailed description of the results and methods, as appeared in the published studies, is shown in <xref rid="pediatrrep-17-00057-t003" ref-type="table">Table 3</xref>.</p><p>Despite the limited number of studies and the heterogeneity in the tasks and analytical techniques used, the extracted coordinates allowed the ALE map calculation (<italic toggle="yes">p</italic> &#x0003c; 0.05, cluster-corrected FWE). The resulting ALE map reveals homogeneous clusters corresponding to the dorsal anterior cingulate cortex (dACC) extending to the supplementary motor cortex (<italic toggle="yes">p</italic> &#x0003c; 0.01). Moreover, bilateral clusters involving the angular gyri and left superior parietal lobe were homogeneous (<italic toggle="yes">p</italic> &#x0003c; 0.0001) (<xref rid="pediatrrep-17-00057-t004" ref-type="table">Table 4</xref>; <xref rid="pediatrrep-17-00057-f002" ref-type="fig">Figure 2</xref>). After that, a series of regions of interest (ROIs) were delineated in correspondence with the principal homogeneous foci, as depicted in <xref rid="pediatrrep-17-00057-f002" ref-type="fig">Figure 2</xref>. For each ROI, a behavioral analysis was carried out using Mango software. Among the six domains included in the analysis (action, cognition, emotion, interoception, and perception), as described by Lancaster et al. [<xref rid="B22-pediatrrep-17-00057" ref-type="bibr">22</xref>], significant z (&#x02265;3) scores for some of the domains and subdomains were found for the homogeneous clusters resulting from the meta-analysis calculation. The analysis carried out for the dACC cluster reveals significant results for the domains of cognition, perception, and action. For cognition, significant results were observed for language speech (z = 5.48), semantics (z = 5.57), and phonology (z = 3.004). Moreover, the subdomains of attention (z = 8.30), working memory (z = 5.39), and reasoning (z = 3.29) showed significant results. The perception (somesthesis z = 3.31; pain z = 5.24; and vision z = 3.76) and action (execution z = 6.60; inhibition z = 4.97; and execution speech z = 3.92) domains yielded significant results. The ROI located in the right SPL was significantly related to cognition (working memory z = 4.56; attention z = 3.45; and reasoning z = 4.18) and perception (vision&#x02013;motion z = 3.30). The subdomain of social cognition was significant for the cluster found in the left angular gyrus, with z = 3.94. No significant results were observed for the cluster found in the right angular gyrus.</p></sec></sec><sec sec-type="discussion" id="sec4-pediatrrep-17-00057"><title>4. Discussion</title><p>The present systematic review aimed to investigate and summarize the principal findings concerning structural and functional brain alterations in children and adolescents affected by multiple sclerosis. Although there is significant interest in multiple sclerosis (MS) among adults, this review focuses on only twenty-one published studies. Most of these studies confirm that the disease is rare in the pediatric population and highlight the challenges of recruiting a sufficient and reliable number of young patients for MRI or fMRI studies. As stated by Yan et al. [<xref rid="B3-pediatrrep-17-00057" ref-type="bibr">3</xref>], who analyzed previous epidemiological studies on pediatric MS, most of those studies were carried out in Europe and North America (Canada), as confirmed by our review. Compared with those who experienced onset in adulthood, 2&#x02013;5% of patients experienced onset in childhood or adolescence [<xref rid="B4-pediatrrep-17-00057" ref-type="bibr">4</xref>,<xref rid="B48-pediatrrep-17-00057" ref-type="bibr">48</xref>]. According to the data published in the included studies, the patients&#x02019; ages ranged between 11 and 15 years, with almost all the patients being adolescents [<xref rid="B49-pediatrrep-17-00057" ref-type="bibr">49</xref>]. During adolescence, patients show single-focal symptoms that are more similar to those observed in adult patients and different from the multifocal symptoms observed in children [<xref rid="B50-pediatrrep-17-00057" ref-type="bibr">50</xref>]. However, the most reported symptoms are sensorial, motor, and brainstem dysfunction. Most of the included studies reported cognitive impairment in participants with MS. Despite this, they focused their attention on the specific domains affected. Indeed, some of their results were based on the administration of an ad hoc neuropsychological battery developed to assess pediatric MS patients (Brief Neuropsychological Battery for Children (BNBC)). This extensive neuropsychological battery includes more than ten scales and subscales that assess intelligence, memory, and working memory; abstract reasoning; and different aspects of language, from phonetics to denomination to semantics and comprehension. However, the results were heterogeneous in terms of the cognitive domains found to be affected. Specific deficits were observed in visuospatial and working memory, language, and attention (<xref rid="pediatrrep-17-00057-t004" ref-type="table">Table 4</xref>). Unlike adult patients, as shown by the included studies, language and intelligence are affected by MS [<xref rid="B51-pediatrrep-17-00057" ref-type="bibr">51</xref>]. These alterations were more frequently observed in cognitively impaired than in cognitively preserved MS patients. However, in a cohort study [<xref rid="B52-pediatrrep-17-00057" ref-type="bibr">52</xref>], 35% of MS pediatric patients presented with cognitive impairment, and the cognitive functions most affected by the disease were motor coordination, visual&#x02013;motor integration, and information-processing speed.</p><p>Most of the included MRI studies used the magnetic resonance protocol suggested in the guidelines for MS [<xref rid="B53-pediatrrep-17-00057" ref-type="bibr">53</xref>], in which fast spin echo or turbo spin echo and FLAIR sequences are recommended for assessing brain lesions in MS.</p><p>Some of the included studies reported specific structural alterations, with a reduced volume in MS patients [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>] or a significantly increased number of lesions in the cerebellum [<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>]. The cerebellum is a complex anatomical structure implicated in several cognitive functions and behavioral and emotional control [<xref rid="B54-pediatrrep-17-00057" ref-type="bibr">54</xref>,<xref rid="B55-pediatrrep-17-00057" ref-type="bibr">55</xref>,<xref rid="B56-pediatrrep-17-00057" ref-type="bibr">56</xref>,<xref rid="B57-pediatrrep-17-00057" ref-type="bibr">57</xref>]. Specifically, since its reciprocal connection with frontal, parietal, and temporal regions, the cerebellum has been found to play a relevant role in language, spatial abilities [<xref rid="B58-pediatrrep-17-00057" ref-type="bibr">58</xref>], and working memory. According to Tedesco et al. [<xref rid="B59-pediatrrep-17-00057" ref-type="bibr">59</xref>], cerebellar lesions do not disrupt specific functions, making them less efficient. However, acquired lesions during childhood can have a different impact than those acquired during adulthood. Despite the anatomical connection and topography of the cerebellum being effective early in life, cerebellar&#x02013;cortical circuits continue to develop during adolescence in parallel with improvements in higher-order cognitive functions, such as language, abstract reasoning, and actions. In a recent multicenter study [<xref rid="B60-pediatrrep-17-00057" ref-type="bibr">60</xref>], during adolescence, all executive functions were present, and complete development was reached in late adolescence, between 18&#x02013;20 years. Mid-adolescence (10&#x02013;15 years) represents a critical period in which the development of these functions is crucial for adulthood. The inferior part of the posterior cerebellar lobe fully develops between 11 and 12 years of age, followed by the anterior lobe and superior portion of the posterior lobe [<xref rid="B61-pediatrrep-17-00057" ref-type="bibr">61</xref>].</p><p>Spatial cognition and, more specifically, goal-directed spatial navigation are some of the functions modulated by the connection between the cerebellum and hippocampus. The hippocampus comprises several subfields with distinctive histological characteristics, neurochemistry, and functions that play different roles in MS [<xref rid="B62-pediatrrep-17-00057" ref-type="bibr">62</xref>,<xref rid="B63-pediatrrep-17-00057" ref-type="bibr">63</xref>,<xref rid="B64-pediatrrep-17-00057" ref-type="bibr">64</xref>]. The hippocampus and its subfields are widely altered in adult MS patients, with an expanded dentate gyrus [<xref rid="B65-pediatrrep-17-00057" ref-type="bibr">65</xref>]. However, these alterations were also observed in pediatric patients with MS. According to the results of the study of Fuentes et al. [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>], no differences were found between patients and controls, whereas Rocca and colleagues [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>] reported atrophy corresponding to the bilateral cornu ammonis, subiculum, and dentate gyrus and hypertrophy of subcomponents of the dentate gyrus in pediatric MS patients. Similarly, the cerebellum and hippocampus show specific trajectories during development from childhood to adulthood [<xref rid="B64-pediatrrep-17-00057" ref-type="bibr">64</xref>]. Several studies have shown that hippocampal volume increases in late childhood and early adolescence, with a peak at 17 years for both girls and boys [<xref rid="B66-pediatrrep-17-00057" ref-type="bibr">66</xref>]. A decreased hippocampal volume can result in detrimental outcomes for several cognitive functions during adulthood.</p><p>The thalamus is one of the cerebral regions most affected by MS. The thalamus includes several nuclei that are involved in cognitive functions, such as selective attention, in which the pulvinar plays a prominent role [<xref rid="B67-pediatrrep-17-00057" ref-type="bibr">67</xref>], and the anterior and medial dorsal nuclei, which are involved in memory encoding and retrieval. Given the high presence of myelin in the thalamus, T1 and T2 lesions are easier to detect than cortical lesions [<xref rid="B68-pediatrrep-17-00057" ref-type="bibr">68</xref>]. Thalamic lesions are very common among MS patients (up to 97%), affecting different types of motor and cognitive functions [<xref rid="B69-pediatrrep-17-00057" ref-type="bibr">69</xref>]. Most of the lesions observed in adult MS patients are subependymal or perivascular. In pediatric MS, a reduction in the volume of the thalamus has been reported, with lesions involving several portions occurring more diffusely than those observed in adult patients.</p><p>Despite the structural alterations, fMRI studies allowed for the decomposition of the cerebral underpinnings of functional alterations in pediatric patients with MS. In addition to the studies conducted on adult patients, the included research examined both resting and task-based brain activity. This led to the identification of a wide range of brain regions consistently involved, including the dACC, the right angular gyrus, and the left superior temporal lobe. The dorsal ACC plays a crucial role in the development of human cognition and behavior. Moreover, the dACC is implicated in the modulation of several cognitive functions, such as motor control, motivation, error detection, working memory, and decision-making [<xref rid="B70-pediatrrep-17-00057" ref-type="bibr">70</xref>,<xref rid="B71-pediatrrep-17-00057" ref-type="bibr">71</xref>]. The involvement of this region in the modulation of these cognitive functions is enabled by the interplay between different functional networks in which different portions of the cingulate cortex play different and relevant roles. The cingulate cortex, more than a specific or unique hub, can be conceived as a crossroad or intersection of different functional networks [<xref rid="B72-pediatrrep-17-00057" ref-type="bibr">72</xref>,<xref rid="B73-pediatrrep-17-00057" ref-type="bibr">73</xref>]. Among the portions in which the cingulate cortex can be anatomofunctionally partitioned [<xref rid="B74-pediatrrep-17-00057" ref-type="bibr">74</xref>], the dACC is frequently coactivated with the bilateral anterior insula, representing the core of the cingulo-opercular (CO) network [<xref rid="B75-pediatrrep-17-00057" ref-type="bibr">75</xref>]. CO and frontoparietal networks play relevant roles in executive functions and processes related to their development during childhood and adolescence [<xref rid="B76-pediatrrep-17-00057" ref-type="bibr">76</xref>]. During a task, these two networks work in different but complementary ways. The frontoparietal network is involved in the starting and adjustment of task control, whereas CO maintains the set during the task. This joint activity is also evident during the resting state [<xref rid="B77-pediatrrep-17-00057" ref-type="bibr">77</xref>], and its organization changes during neurodevelopment.</p><p>None of the studies that we included reported specific alterations in the crosstalk between the bilateral insular cortex and the dACC. However, cognitively preserved patients presented increased functional connectivity in the ACC [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>]. Moreover, De Meo et al. [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>] reported lower FA values in the tracts connecting the left anterior insula to the anterior cingulate cortex in patients with cognitive impairment than in those without cognitive impairment. Therefore, during an attention load task, decreased deactivation was observed in the ACC when the BOLD response of cognitively preserved patients was compared with that of healthy subjects, suggesting that MS during adolescence may disrupt the functional architecture of the CO network, particularly in patients with cognitive impairment. The development of executive functions depends on several factors, such as synaptic pruning and myelination [<xref rid="B78-pediatrrep-17-00057" ref-type="bibr">78</xref>,<xref rid="B79-pediatrrep-17-00057" ref-type="bibr">79</xref>].</p><p>The relevance of its key role has also been confirmed by the results of the behavioral analysis, which highlighted the role of the dACC in cognition and its subdomains, attention, working memory, and reasoning. These latter genes were found to be altered in children and adolescents with MS, as mentioned above. The dorsal ACC is hypothesized to play a central role in decisions about the allocation of cognitive control on the basis of the highest expected value of control [<xref rid="B73-pediatrrep-17-00057" ref-type="bibr">73</xref>]. This complex function seems to be affected by pediatric MS, with sequelae of other cognitive functions. In this way, future studies should assess the role of the cingulate cortex in pediatric patients with MS, using complex multimodal MRI and fMRI paradigms, which could improve the integrity of the NAWM between the anterior cingulate cortex and insula. For instance, recent radiomic approaches, particularly those utilizing T2-FLAIR imaging, have demonstrated promising results in characterizing demyelinating lesions in pediatric multiple sclerosis patients, providing new possibilities for differential diagnosis and aiding in the automation of imaging analysis procedures [<xref rid="B80-pediatrrep-17-00057" ref-type="bibr">80</xref>].</p><p>Interestingly, four studies [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>,<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>,<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>,<xref rid="B41-pediatrrep-17-00057" ref-type="bibr">41</xref>] investigated brain activity in the resting state, analyzing alterations in networks such as the default mode network (DMN). The DMN was first defined as a set of regions whose activity increased during the resting state [<xref rid="B81-pediatrrep-17-00057" ref-type="bibr">81</xref>]. This network is composed of three specialized subsystems: the ventromedial prefrontal cortex (vmPFC), the dorsomedial prefrontal cortex (dmPFC), and the PCC, precuneus, and lateral parietal cortex [<xref rid="B82-pediatrrep-17-00057" ref-type="bibr">82</xref>]. All these brain regions are involved in self-related cognitive functions, such as rumination, introspection, self-reflective thoughts, and autobiographical memory, in which theory of mind (ToM) plays a key role [<xref rid="B83-pediatrrep-17-00057" ref-type="bibr">83</xref>,<xref rid="B84-pediatrrep-17-00057" ref-type="bibr">84</xref>]. The theory of mind allows one to infer the mental state of another, with attributions to their knowledge, beliefs, and emotions [<xref rid="B85-pediatrrep-17-00057" ref-type="bibr">85</xref>]. Among the three systems mentioned above, the dmPFC strongly overlapped with ToM-related processes. Unfortunately, none of the four fMRI studies reported specific alterations in functional connectivity in the dmPFC but reported alterations in DMN FC in the comparison between patients and controls. Alterations in social cognition and ToM were observed in cross-sectional case&#x02013;control studies comparing pediatric patients with MS and healthy controls [<xref rid="B86-pediatrrep-17-00057" ref-type="bibr">86</xref>,<xref rid="B87-pediatrrep-17-00057" ref-type="bibr">87</xref>,<xref rid="B88-pediatrrep-17-00057" ref-type="bibr">88</xref>]. In pediatric patients, worse performance in both affective and cognitive measures has been reported [<xref rid="B86-pediatrrep-17-00057" ref-type="bibr">86</xref>], and patients with disease onset before 15 y.o. had significantly lower ToM scores [<xref rid="B88-pediatrrep-17-00057" ref-type="bibr">88</xref>]. According to a recent meta-analysis, moderate impairments in empathy, overall ToM, cognitive ToM, and the overlapping domains of cognitive empathy/affective ToM were observed in adults with multiple sclerosis. Although these results revealed an impairment in ToM in both adults and pediatric patients, the associations between impairments in social cognition and alterations in the functional connectivity of the DMN have not yet been studied.</p><p>Despite the potential role of the ACC in disentangling some aspects of MS, a series of limitations needs to be acknowledged. We have conducted an ALE meta-analysis on a few studies, demonstrating that MS in pediatric patients is a rare syndrome, with great effort in conducting neuroimaging studies. Importantly, the conclusions drawn from the ALE meta-analysis results should be interpreted cautiously due to the variability in protocols, tasks, and sample sizes across the included studies.</p></sec><sec sec-type="conclusions" id="sec5-pediatrrep-17-00057"><title>5. Conclusions</title><p>In summary, this comprehensive review provides insights into the complex landscape of brain structural and functional changes in children and adolescents affected by multiple sclerosis (MS). Despite the rarity of MS in the pediatric population, research highlights the necessity of comprehending its impact on young individuals.</p><p>This review suggests that the onset of MS during childhood or adolescence presents unique clinical features, with adolescents often displaying symptoms more similar to those observed in adults. Cognitive impairment has emerged as a significant issue, encompassing deficits in various areas such as visuospatial abilities, working memory, language, and attention. Additionally, the involvement of critical regions such as the cerebellum and hippocampus, which are essential for cognitive and spatial functions, underscores the extensive effects of MS on neurodevelopment during these crucial years.</p><p>Structural changes, notably in the thalamus, further emphasize the complexity of MS pathology in pediatric patients. Early detection of structural alterations in these regions, as well as the number of lesions, can help assess the progression of the disease and monitor clinical strategies and interventions.</p><p>While MRI studies reveal specific anatomical alterations, functional MRI sheds light on the underlying neural mechanisms driving cognitive dysfunction, with the dorsal anterior cingulate cortex emerging as a pivotal region implicated in various cognitive processes.</p><p>These findings contribute to our understanding of MS pathophysiology in young individuals and underscore the importance of early detection and intervention to alleviate cognitive impairments and improve long-term outcomes. In the future, sustained research efforts are necessary to elucidate the intricate relationship between MS pathology and neurodevelopment, ultimately guiding tailored therapeutic approaches for the unique needs of pediatric MS patients.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, N.C. and R.F.; methodology, N.C. and J.P.; software, N.C.; validation, N.C. and R.F.; formal analysis, N.C.; investigation, N.C., R.F., and J.P.; data curation, N.C., R.F., and J.P.; writing&#x02014;original draft preparation, N.C.; writing&#x02014;review and editing, N.C. and R.F.; visualization, N.C.; supervision, R.F. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><app-group><app id="app1-pediatrrep-17-00057"><title>Appendix A. Neuropsychological Assessment as Reported in the Included Studies</title><array><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Source</bold>
</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Tests/Batteries</bold>
</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Cognitive Domains</bold>
</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Results</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cirillo et al. 2016 [<xref rid="B24-pediatrrep-17-00057" ref-type="bibr">24</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuropsychological Battery for Pediatric Patients Affected by MS.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19% of patients were cognitively impaired.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Meo et al., 2017 [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modified Card Sorting Test; Oral Denomination Test; Phrase Comprehension Test; Symbol Digit Modalities Test; Spatial Recall Test; Spatial Recall Test Delayed; Selective Reminding Test Consistent Long-Term Retrieval; Selective Reminding Test Delayed; Selective Reminding Test <break/> Long-Term Storage; Trail Making Test A/B.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abstract and conceptual Reasoning <break/> Memory <break/> Language <break/> Attention</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23% of MS patients were classified as cognitively impaired. <break/> 36% of the cognitively impaired patients and none of the cognitively preserved patients had impairment on attention tests.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fuentes et al., 2012 [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Test of Memory and Learning&#x02014;Second Edition (TOMAL-2) Subscales: Word Selective Reminding, Memory for Stories, Abstract Visual Memory, and Facial Memory.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Memory</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Overall, lower memory scores in the MS group compared to the HC. <break/> All of the patients performed at least within the age-expected level on a measure of delayed, unaided recall of a word list, suggesting that verbal information was well-consolidated for later retrieval.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hubacher et al., 2015 [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corsi Blocks Backward; Digit Span Backward; Symbol Digit Modalities Test; Test Battery for Attention Performance (TAP).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Working memory functions and basic attention</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No working memory deficits compared with normative data.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>] </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brief Neuropsychological Battery for Children (BNBC). <break/> Selective Reminding Test (SRT, SRT-Delayed); Spatial Recall Test (SPART, SPART-Delayed); Symbol Digit Modalities Test; <break/> Trail Making Test (TMT-A/B); Modified Card Sorting Test; <break/> Semantic and Phonemic Verbal Fluency Test; Oral Denomination Test; Token Test, the Indication of Pictures; Battery for the Analysis of Aphasic Deficits.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Memory <break/> Language, sustained attention <break/> Abstract reasoning</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45% of patients were classified as cognitively impaired. <break/> The cognitive domains most frequently involved were spatial and verbal memory, language, and attention.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>] </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brief Neuropsychological Battery for Children (BNBC).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Global cognitive functioning, verbal learning and delayed recall, visuospatial learning and delayed recall, sustained attention and concentration, abstract reasoning, expressive language, and receptive language</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 pediatric MS patients were CP.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Margoni et al., 2020 [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trail Making Test&#x02014;Part B (TMT-B); <break/> Symbol Digit Modalities Test&#x02014;oral version (SDMT).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Executive functioning, cognitive flexibility</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Normal performance on neuropsychological tests.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Weier et al., 2016 [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wechsler Abbreviated Scale of Intelligence (WASI FSIQ); Trail Making Test&#x02014;Part B (TMT-B); Symbol Digit Modalities Test&#x02014;Oral Version (SDMT); Beery Visual Motor Integration (VMI); Vocabulary Subtest of the WASI; Grooved Pegboard Test.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intelligence, cognitive flexibility, language, and motor skills</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients showed impaired performance (defined as performance falling &#x02265; 1.5 SD below normative values) in the following subtests: TMT B, VMI, SDMT, and the Pegboard Test.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacciaguerra et al., 2024 [<xref rid="B41-pediatrrep-17-00057" ref-type="bibr">41</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wechsler Intelligence Scale for children (WISC); Wechsler Adult Intelligence Scale (WAIS); Neuropsychological Battery for Children; Symbol Digit Modalities Test (SDMT); Coding Design (CD); Trail Making Test A-B (TMT-A/TMT-B); Semantic Verbal Fluency Test (SVFT); Phonemic Verbal Fluency Test (PVFT).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IQ, executive speed, and expressive language</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.1% of patients failed the CD, 15.8% the TMT-B, 10.5% the TMT-A, 9.2% the SDMT, 3.9% the PVFT, 6.6% the BD, and 1.3% the SVFT.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green et al., 2018 [<xref rid="B40-pediatrrep-17-00057" ref-type="bibr">40</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Behavior Assessment System for Children, Second Edition: Parent Rating Scale (BASC-2 PRS): Social Skills and Functional Communication Subscales; <break/> Wechsler Abbreviated Scale of Intelligence (WASI); Test of Memory and Learning&#x02014;2nd Edition (TOMAL-2) Subscales: Memory for Stories, Word Selective Reminding, Facial Memory, and Abstract Visual Memory; Children&#x02019;s Depression Inventory (CDI); Fatigue Severity Scale (FSS); Selective Reminding Test (SRT&#x02014;Consistent Long-Term Retrieval and SRT&#x02014;Long-Term Storage); Spatial Recall Test (SPART and SPART-Delayed); Symbol Digit Modalities Test (SDMT); Trail Making Test A-B (TMT-A/TMT-B); Modified Card Sorting Test (MCST); Indication of Pictures Test (IPT); Phrase Comprehension Test (PCT).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Social skills and functional <break/> communication <break/> Verbal and nonverbal socialization <break/> Expressive and receptive communication skills <break/> Verbal memory (delayed condition and delayed recall) and visual&#x02013;spatial memory function</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Full-scale IQ was higher in the HC group relative to the MS group, although groups fell within the broad range of average for IQ. <break/> Relative to the HC group, patients performed significantly worse on the MFS-D and AVM subtests of the TOMAL-2. They were reported as having poorer functional communication skills on the BASC-2. <break/> Performance fell in the impaired range in 9.4% of patients in the MFS-D subtest and only 3.1% of patients in the AVM subtest. <break/> Clinically elevated scores were observed in 12.5% of patients regarding functional communication and 3.1% on the Social Skills BASC-2 scale.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., <break/> 2016 [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selective Reminding Test <break/> (SRT); Spatial Recall Test (SPART)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Long-term storage, consistent long-term <break/> retrieval and delayed <break/> visuospatial&#x02013;spatial recall</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.6% of patients were CI. <break/> Two patients scored &#x0003c; 70 in IQ, and twelve scored in the inferior range (&#x0003c;90). <break/> The cognitive domains most frequently <break/> involved were spatial memory, <break/> verbal memory, language abilities, attention, and concentration functions.</td></tr></tbody></array></app></app-group><ref-list><title>References</title><ref id="B1-pediatrrep-17-00057"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Waldman</surname><given-names>A.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Bar-Or</surname><given-names>A.</given-names></name>
<name><surname>Mikaeloff</surname><given-names>Y.</given-names></name>
<name><surname>Tardieu</surname><given-names>M.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
</person-group><article-title>Multiple sclerosis in children: An update on clinical diagnosis, therapeutic strategies, and research</article-title><source>Lancet Neurol.</source><year>2014</year><volume>13</volume><fpage>936</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(14)70093-6</pub-id><pub-id pub-id-type="pmid">25142460</pub-id>
</element-citation></ref><ref id="B2-pediatrrep-17-00057"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narula</surname><given-names>S.</given-names></name>
</person-group><article-title>Pediatric multiple sclerosis: Updates in epidemiology, clinical features and management</article-title><source>Neurodegener Dis. Manag.</source><year>2016</year><volume>6</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2217/nmt-2016-0046</pub-id><pub-id pub-id-type="pmid">27874494</pub-id>
</element-citation></ref><ref id="B3-pediatrrep-17-00057"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>K.</given-names></name>
<name><surname>Balijepalli</surname><given-names>C.</given-names></name>
<name><surname>Desai</surname><given-names>K.</given-names></name>
<name><surname>Gullapalli</surname><given-names>L.</given-names></name>
<name><surname>Druyts</surname><given-names>E.</given-names></name>
</person-group><article-title>Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis</article-title><source>Mult. Scler. Relat. Disord.</source><year>2020</year><volume>44</volume><fpage>102260</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2020.102260</pub-id><pub-id pub-id-type="pmid">32540746</pub-id>
</element-citation></ref><ref id="B4-pediatrrep-17-00057"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Bar-Or</surname><given-names>A.</given-names></name>
<name><surname>Mikaeloff</surname><given-names>Y.</given-names></name>
<name><surname>Tardieu</surname><given-names>M.</given-names></name>
</person-group><article-title>Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions</article-title><source>Lancet Neurol.</source><year>2007</year><volume>6</volume><fpage>887</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(07)70242-9</pub-id><pub-id pub-id-type="pmid">17884679</pub-id>
</element-citation></ref><ref id="B5-pediatrrep-17-00057"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brownlee</surname><given-names>W.J.</given-names></name>
<name><surname>Altmann</surname><given-names>D.R.</given-names></name>
<name><surname>Alves Da Mota</surname><given-names>P.</given-names></name>
<name><surname>Swanton</surname><given-names>J.K.</given-names></name>
<name><surname>Miszkiel</surname><given-names>K.A.</given-names></name>
<name><surname>Wheeler-Kingshott</surname><given-names>C.G.</given-names></name>
<name><surname>Ciccarelli</surname><given-names>O.</given-names></name>
<name><surname>Miller</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome</article-title><source>Mult. Scler. J.</source><year>2017</year><volume>23</volume><fpage>665</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1177/1352458516663034</pub-id></element-citation></ref><ref id="B6-pediatrrep-17-00057"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palavra</surname><given-names>F.</given-names></name>
<name><surname>Silva</surname><given-names>D.</given-names></name>
<name><surname>Fernandes</surname><given-names>C.</given-names></name>
<name><surname>Faustino</surname><given-names>R.</given-names></name>
<name><surname>Vasconcelos</surname><given-names>M.</given-names></name>
<name><surname>Pereira</surname><given-names>C.</given-names></name>
<name><surname>Costa</surname><given-names>C.</given-names></name>
<name><surname>Ribeiro</surname><given-names>J.A.</given-names></name>
<name><surname>Amaral</surname><given-names>J.</given-names></name>
<name><surname>Robalo</surname><given-names>C.</given-names></name>
</person-group><article-title>Clinical predictors of NEDA-3 one year after diagnosis of pediatric multiple sclerosis: An exploratory single-center study</article-title><source>Front. Neurosci.</source><year>2023</year><volume>17</volume><elocation-id>1259306</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2023.1259306</pub-id><pub-id pub-id-type="pmid">37781240</pub-id>
</element-citation></ref><ref id="B7-pediatrrep-17-00057"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Carvalho</surname><given-names>S.</given-names></name>
<name><surname>Pinto</surname><given-names>J.</given-names></name>
<name><surname>Correia</surname><given-names>I.</given-names></name>
<name><surname>Faustino</surname><given-names>R.</given-names></name>
<name><surname>Vasconcelos</surname><given-names>M.</given-names></name>
<name><surname>Sousa</surname><given-names>L.</given-names></name>
<name><surname>Palavra</surname><given-names>F.</given-names></name>
</person-group><article-title>Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis</article-title><source>Acta Med. Port.</source><year>2021</year><volume>34</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.20344/amp.12486</pub-id><pub-id pub-id-type="pmid">33241993</pub-id>
</element-citation></ref><ref id="B8-pediatrrep-17-00057"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mikaeloff</surname><given-names>Y.</given-names></name>
<name><surname>Caridade</surname><given-names>G.</given-names></name>
<name><surname>Assi</surname><given-names>S.</given-names></name>
<name><surname>Suissa</surname><given-names>S.</given-names></name>
<name><surname>Tardieu</surname><given-names>M.</given-names></name>
</person-group><article-title>Prognostic factors for early severity in a childhood multiple sclerosis cohort</article-title><source>Pediatrics</source><year>2006</year><volume>118</volume><fpage>1133</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-0655</pub-id><pub-id pub-id-type="pmid">16951008</pub-id>
</element-citation></ref><ref id="B9-pediatrrep-17-00057"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iaffaldano</surname><given-names>P.</given-names></name>
<name><surname>Simone</surname><given-names>M.</given-names></name>
<name><surname>Lucisano</surname><given-names>G.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Coniglio</surname><given-names>G.</given-names></name>
<name><surname>Brescia Morra</surname><given-names>V.</given-names></name>
<name><surname>Salemi</surname><given-names>G.</given-names></name>
<name><surname>Patti</surname><given-names>F.</given-names></name>
<name><surname>Lugaresi</surname><given-names>A.</given-names></name>
<name><surname>Izquierdo</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Prognostic indicators in pediatric clinically isolated syndrome</article-title><source>Ann. Neurol.</source><year>2017</year><volume>81</volume><fpage>729</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1002/ana.24938</pub-id><pub-id pub-id-type="pmid">28439957</pub-id>
</element-citation></ref><ref id="B10-pediatrrep-17-00057"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Glover</surname><given-names>G.H.</given-names></name>
</person-group><article-title>Overview of functional magnetic resonance imaging</article-title><source>Neurosurg. Clin. N. Am.</source><year>2011</year><volume>22</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.nec.2010.11.001</pub-id><pub-id pub-id-type="pmid">21435566</pub-id>
</element-citation></ref><ref id="B11-pediatrrep-17-00057"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Schoonheim</surname><given-names>M.M.</given-names></name>
<name><surname>Valsasina</surname><given-names>P.</given-names></name>
<name><surname>Geurts</surname><given-names>J.J.G.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective</article-title><source>Neuroimage Clin.</source><year>2022</year><volume>35</volume><fpage>103076</fpage><pub-id pub-id-type="doi">10.1016/j.nicl.2022.103076</pub-id><pub-id pub-id-type="pmid">35691253</pub-id>
</element-citation></ref><ref id="B12-pediatrrep-17-00057"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laura</surname><given-names>G.</given-names></name>
<name><surname>Silvia</surname><given-names>T.</given-names></name>
<name><surname>Nikolaos</surname><given-names>P.</given-names></name>
<name><surname>Patrizia</surname><given-names>P.</given-names></name>
</person-group><article-title>The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review</article-title><source>Neural. Plast.</source><year>2018</year><volume>2018</volume><fpage>3419871</fpage><pub-id pub-id-type="doi">10.1155/2018/3419871</pub-id><pub-id pub-id-type="pmid">30693023</pub-id>
</element-citation></ref><ref id="B13-pediatrrep-17-00057"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Liberati</surname><given-names>A.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.</given-names></name>
<name><surname>Altman</surname><given-names>D.G.</given-names></name>
<collab>PRISMA Group</collab>
</person-group><article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</article-title><source>PLoS Med.</source><year>2009</year><volume>6</volume><elocation-id>e1000097</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id>
</element-citation></ref><ref id="B14-pediatrrep-17-00057"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>bmj</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation></ref><ref id="B15-pediatrrep-17-00057"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cera</surname><given-names>N.</given-names></name>
<name><surname>Vargas-C&#x000e1;ceres</surname><given-names>S.</given-names></name>
<name><surname>Oliveira</surname><given-names>C.</given-names></name>
<name><surname>Monteiro</surname><given-names>J.</given-names></name>
<name><surname>Branco</surname><given-names>D.</given-names></name>
<name><surname>Pignatelli</surname><given-names>D.</given-names></name>
<name><surname>Rebelo</surname><given-names>S.</given-names></name>
</person-group><article-title>How relevant is the systemic oxytocin concentration for human sexual behavior? A systematic review</article-title><source>Sex. Med.</source><year>2021</year><volume>9</volume><fpage>100370</fpage><pub-id pub-id-type="doi">10.1016/j.esxm.2021.100370</pub-id><pub-id pub-id-type="pmid">34118520</pub-id>
</element-citation></ref><ref id="B16-pediatrrep-17-00057"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vargas-C&#x000e1;ceres</surname><given-names>S.</given-names></name>
<name><surname>Cera</surname><given-names>N.</given-names></name>
<name><surname>Nobre</surname><given-names>P.</given-names></name>
<name><surname>Ramos-Quiroga</surname><given-names>J.A.</given-names></name>
</person-group><article-title>The impact of psychosis on sexual functioning: A systematic review</article-title><source>J. Sex. Med.</source><year>2021</year><volume>18</volume><fpage>457</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.jsxm.2020.12.007</pub-id><pub-id pub-id-type="pmid">33504468</pub-id>
</element-citation></ref><ref id="B17-pediatrrep-17-00057"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Filippi</surname><given-names>M.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Ciccarelli</surname><given-names>O.</given-names></name>
<name><surname>De Stefano</surname><given-names>N.</given-names></name>
<name><surname>Evangelou</surname><given-names>N.</given-names></name>
<name><surname>Kappos</surname><given-names>L.</given-names></name>
<name><surname>Rovira</surname><given-names>A.</given-names></name>
<name><surname>Sastre-Garriga</surname><given-names>J.</given-names></name>
<name><surname>Tintor&#x000e8;</surname><given-names>M.</given-names></name>
<name><surname>Frederiksen</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines</article-title><source>Lancet Neurol.</source><year>2016</year><volume>15</volume><fpage>292</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(15)00393-2</pub-id><pub-id pub-id-type="pmid">26822746</pub-id>
</element-citation></ref><ref id="B18-pediatrrep-17-00057"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krupp</surname><given-names>L.B.</given-names></name>
<name><surname>Tardieu</surname><given-names>M.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Chitnis</surname><given-names>T.</given-names></name>
<name><surname>Dale</surname><given-names>R.C.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Hintzen</surname><given-names>R.</given-names></name>
<name><surname>Kornberg</surname><given-names>A.</given-names></name>
<name><surname>Pohl</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions</article-title><source>Mult. Scler. J.</source><year>2013</year><volume>19</volume><fpage>1261</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1177/1352458513484547</pub-id><pub-id pub-id-type="pmid">23572237</pub-id>
</element-citation></ref><ref id="B19-pediatrrep-17-00057"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Turkeltaub</surname><given-names>P.E.</given-names></name>
<name><surname>Eickhoff</surname><given-names>S.B.</given-names></name>
<name><surname>Laird</surname><given-names>A.R.</given-names></name>
<name><surname>Fox</surname><given-names>M.</given-names></name>
<name><surname>Wiener</surname><given-names>M.</given-names></name>
<name><surname>Fox</surname><given-names>P.</given-names></name>
</person-group><article-title>Minimizing within-experiment and within-group effects in activation likelihood estimation meta-analyses</article-title><source>Hum. Brain Mapp.</source><year>2012</year><volume>33</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/hbm.21186</pub-id><pub-id pub-id-type="pmid">21305667</pub-id>
</element-citation></ref><ref id="B20-pediatrrep-17-00057"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eickhoff</surname><given-names>S.B.</given-names></name>
<name><surname>Bzdok</surname><given-names>D.</given-names></name>
<name><surname>Laird</surname><given-names>A.R.</given-names></name>
<name><surname>Kurth</surname><given-names>F.</given-names></name>
<name><surname>Fox</surname><given-names>P.T.</given-names></name>
</person-group><article-title>Activation likelihood estimation meta-analysis revisited</article-title><source>Neuroimage</source><year>2012</year><volume>59</volume><fpage>2349</fpage><lpage>2361</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.017</pub-id><pub-id pub-id-type="pmid">21963913</pub-id>
</element-citation></ref><ref id="B21-pediatrrep-17-00057"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lancaster</surname><given-names>J.L.</given-names></name>
<name><surname>Cykowski</surname><given-names>M.D.</given-names></name>
<name><surname>McKay</surname><given-names>D.R.</given-names></name>
<name><surname>Kochunov</surname><given-names>P.V.</given-names></name>
<name><surname>Fox</surname><given-names>P.T.</given-names></name>
<name><surname>Rogers</surname><given-names>W.</given-names></name>
<name><surname>Toga</surname><given-names>A.W.</given-names></name>
<name><surname>Zilles</surname><given-names>K.</given-names></name>
<name><surname>Amunts</surname><given-names>K.</given-names></name>
<name><surname>Mazziotta</surname><given-names>J.</given-names></name>
</person-group><article-title>Anatomical global spatial normalization</article-title><source>Neuroinformatics</source><year>2010</year><volume>8</volume><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/s12021-010-9074-x</pub-id><pub-id pub-id-type="pmid">20582489</pub-id>
</element-citation></ref><ref id="B22-pediatrrep-17-00057"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lancaster</surname><given-names>J.L.</given-names></name>
<name><surname>Laird</surname><given-names>A.R.</given-names></name>
<name><surname>Eickhoff</surname><given-names>S.B.</given-names></name>
<name><surname>Martinez</surname><given-names>M.J.</given-names></name>
<name><surname>Fox</surname><given-names>P.M.</given-names></name>
<name><surname>Fox</surname><given-names>P.T.</given-names></name>
</person-group><article-title>Automated regional behavioral analysis for human brain images</article-title><source>Front. Neuroinform.</source><year>2012</year><volume>6</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.3389/fninf.2012.00023</pub-id><pub-id pub-id-type="pmid">22973224</pub-id>
</element-citation></ref><ref id="B23-pediatrrep-17-00057"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aubert-Broche</surname><given-names>B.</given-names></name>
<name><surname>Fonov</surname><given-names>V.</given-names></name>
<name><surname>Ghassemi</surname><given-names>R.</given-names></name>
<name><surname>Narayanan</surname><given-names>S.</given-names></name>
<name><surname>Arnold</surname><given-names>D.L.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Sled</surname><given-names>J.G.</given-names></name>
<name><surname>Collins</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Regional brain atrophy in children with multiple sclerosis</article-title><source>Neuroimage</source><year>2011</year><volume>58</volume><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.03.025</pub-id><pub-id pub-id-type="pmid">21414412</pub-id>
</element-citation></ref><ref id="B24-pediatrrep-17-00057"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cirillo</surname><given-names>S.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Valsasina</surname><given-names>P.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<name><surname>Falini</surname><given-names>A.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2016</year><volume>22</volume><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1177/1352458515592191</pub-id></element-citation></ref><ref id="B25-pediatrrep-17-00057"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Absinta</surname><given-names>M.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?</article-title><source>Hum. Brain Mapp.</source><year>2009</year><volume>30</volume><fpage>2844</fpage><lpage>2851</lpage><pub-id pub-id-type="doi">10.1002/hbm.20712</pub-id><pub-id pub-id-type="pmid">19107755</pub-id>
</element-citation></ref><ref id="B26-pediatrrep-17-00057"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Meo</surname><given-names>E.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Capra</surname><given-names>R.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Pagani</surname><given-names>E.</given-names></name>
<name><surname>Fiorino</surname><given-names>A.</given-names></name>
<name><surname>Pippolo</surname><given-names>L.</given-names></name>
<name><surname>Pera</surname><given-names>M.C.</given-names></name>
<etal/>
</person-group><article-title>MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients</article-title><source>Neurology</source><year>2017</year><volume>89</volume><fpage>1265</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000004388</pub-id><pub-id pub-id-type="pmid">28821687</pub-id>
</element-citation></ref><ref id="B27-pediatrrep-17-00057"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fuentes</surname><given-names>A.</given-names></name>
<name><surname>Collins</surname><given-names>D.L.</given-names></name>
<name><surname>Garcia-Lorenzo</surname><given-names>D.</given-names></name>
<name><surname>Sled</surname><given-names>J.G.</given-names></name>
<name><surname>Narayanan</surname><given-names>S.</given-names></name>
<name><surname>Arnold</surname><given-names>D.L.</given-names></name>
<name><surname>Banwell</surname><given-names>B.L.</given-names></name>
<name><surname>Till</surname><given-names>C.</given-names></name>
</person-group><article-title>Memory performance and normalized regional brain volumes in patients with pediatric-onset multiple sclerosis</article-title><source>J. Int. Neuropsychol. Soc.</source><year>2012</year><volume>18</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1017/S1355617711001913</pub-id><pub-id pub-id-type="pmid">22321690</pub-id>
</element-citation></ref><ref id="B28-pediatrrep-17-00057"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Absinta</surname><given-names>M.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Colombo</surname><given-names>B.</given-names></name>
<name><surname>Martinelli</surname><given-names>V.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis</article-title><source>Radiology</source><year>2010</year><volume>254</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1148/radiol.09090463</pub-id><pub-id pub-id-type="pmid">20093525</pub-id>
</element-citation></ref><ref id="B29-pediatrrep-17-00057"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Absinta</surname><given-names>M.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Capra</surname><given-names>R.</given-names></name>
<name><surname>Portaccio</surname><given-names>E.</given-names></name>
<name><surname>Fiorino</surname><given-names>A.</given-names></name>
<name><surname>Pippolo</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Posterior brain damage and cognitive impairment in pediatric multiple sclerosis</article-title><source>Neurology</source><year>2014</year><volume>82</volume><fpage>1314</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000309</pub-id><pub-id pub-id-type="pmid">24647027</pub-id>
</element-citation></ref><ref id="B30-pediatrrep-17-00057"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Sonkin</surname><given-names>M.</given-names></name>
<name><surname>Copetti</surname><given-names>M.</given-names></name>
<name><surname>Pagani</surname><given-names>E.</given-names></name>
<name><surname>Arnold</surname><given-names>D.L.</given-names></name>
<name><surname>Narayanan</surname><given-names>S.</given-names></name>
<name><surname>Sled</surname><given-names>J.G.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2016</year><volume>22</volume><fpage>620</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1177/1352458515596600</pub-id></element-citation></ref><ref id="B31-pediatrrep-17-00057"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Valsasina</surname><given-names>P.</given-names></name>
<name><surname>Absinta</surname><given-names>M.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Horsfield</surname><given-names>M.A.</given-names></name>
<name><surname>Falini</surname><given-names>A.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis</article-title><source>Hum. Brain Mapp.</source><year>2014</year><volume>35</volume><fpage>4180</fpage><lpage>4192</lpage><pub-id pub-id-type="doi">10.1002/hbm.22469</pub-id><pub-id pub-id-type="pmid">24510680</pub-id>
</element-citation></ref><ref id="B32-pediatrrep-17-00057"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Morelli</surname><given-names>M.E.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Capra</surname><given-names>R.</given-names></name>
<name><surname>Pagani</surname><given-names>E.</given-names></name>
<name><surname>Portaccio</surname><given-names>E.</given-names></name>
<name><surname>Fiorino</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2016</year><volume>22</volume><fpage>628</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1177/1352458515598569</pub-id><pub-id pub-id-type="pmid">26286701</pub-id>
</element-citation></ref><ref id="B33-pediatrrep-17-00057"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ceccarelli</surname><given-names>A.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Perego</surname><given-names>E.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Martinelli</surname><given-names>V.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2011</year><volume>17</volume><fpage>702</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1177/1352458510395645</pub-id><pub-id pub-id-type="pmid">21228024</pub-id>
</element-citation></ref><ref id="B34-pediatrrep-17-00057"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bartels</surname><given-names>F.</given-names></name>
<name><surname>Nobis</surname><given-names>K.</given-names></name>
<name><surname>Cooper</surname><given-names>G.</given-names></name>
<name><surname>Wendel</surname><given-names>E.</given-names></name>
<name><surname>Cleaveland</surname><given-names>R.</given-names></name>
<name><surname>Bajer-Kornek</surname><given-names>B.</given-names></name>
<name><surname>Blaschek</surname><given-names>A.</given-names></name>
<name><surname>Schimmel</surname><given-names>M.</given-names></name>
<name><surname>Blankenburg</surname><given-names>M.</given-names></name>
<name><surname>Baumann</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure</article-title><source>Mult. Scler. J.</source><year>2019</year><volume>25</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1177/1352458519829698</pub-id></element-citation></ref><ref id="B35-pediatrrep-17-00057"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Meo</surname><given-names>E.</given-names></name>
<name><surname>Bonacchi</surname><given-names>R.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Colombo</surname><given-names>B.</given-names></name>
<name><surname>Sangalli</surname><given-names>F.</given-names></name>
<name><surname>Zanetta</surname><given-names>C.</given-names></name>
<name><surname>Amato</surname><given-names>M.P.</given-names></name>
<name><surname>Martinelli</surname><given-names>V.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
</person-group><article-title>Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis</article-title><source>Ann. Neurol.</source><year>2021</year><volume>89</volume><fpage>1011</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1002/ana.26052</pub-id><pub-id pub-id-type="pmid">33598931</pub-id>
</element-citation></ref><ref id="B36-pediatrrep-17-00057"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hubacher</surname><given-names>M.</given-names></name>
<name><surname>DeLuca</surname><given-names>J.</given-names></name>
<name><surname>Weber</surname><given-names>P.</given-names></name>
<name><surname>Steinlin</surname><given-names>M.</given-names></name>
<name><surname>Kappos</surname><given-names>L.</given-names></name>
<name><surname>Opwis</surname><given-names>K.</given-names></name>
<name><surname>Penner</surname><given-names>I.K.</given-names></name>
</person-group><article-title>Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity</article-title><source>Restor. Neurol. Neurosci.</source><year>2015</year><volume>33</volume><fpage>713</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.3233/RNN-150497</pub-id><pub-id pub-id-type="pmid">25835556</pub-id>
</element-citation></ref><ref id="B37-pediatrrep-17-00057"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Margoni</surname><given-names>M.</given-names></name>
<name><surname>Franciotta</surname><given-names>S.</given-names></name>
<name><surname>Poggiali</surname><given-names>D.</given-names></name>
<name><surname>Riccardi</surname><given-names>A.</given-names></name>
<name><surname>Rinaldi</surname><given-names>F.</given-names></name>
<name><surname>Nosadini</surname><given-names>M.</given-names></name>
<name><surname>Sartori</surname><given-names>S.</given-names></name>
<name><surname>Anglani</surname><given-names>M.G.</given-names></name>
<name><surname>Causin</surname><given-names>F.</given-names></name>
<name><surname>Perini</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset</article-title><source>J. Neurol.</source><year>2020</year><volume>267</volume><fpage>1824</fpage><lpage>1829</lpage><pub-id pub-id-type="doi">10.1007/s00415-020-09776-6</pub-id><pub-id pub-id-type="pmid">32140864</pub-id>
</element-citation></ref><ref id="B38-pediatrrep-17-00057"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weier</surname><given-names>K.</given-names></name>
<name><surname>Till</surname><given-names>C.</given-names></name>
<name><surname>Fonov</surname><given-names>V.</given-names></name>
<name><surname>Yeh</surname><given-names>E.A.</given-names></name>
<name><surname>Arnold</surname><given-names>D.L.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Collins</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2016</year><volume>22</volume><fpage>599</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1177/1352458515595132</pub-id></element-citation></ref><ref id="B39-pediatrrep-17-00057"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kerbrat</surname><given-names>A.</given-names></name>
<name><surname>Aubert-Broche</surname><given-names>B.</given-names></name>
<name><surname>Fonov</surname><given-names>V.</given-names></name>
<name><surname>Narayanan</surname><given-names>S.</given-names></name>
<name><surname>Sled</surname><given-names>J.G.</given-names></name>
<name><surname>Arnold</surname><given-names>D.A.</given-names></name>
<name><surname>Banwell</surname><given-names>B.</given-names></name>
<name><surname>Collins</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS</article-title><source>Neurology</source><year>2012</year><volume>78</volume><fpage>194</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318240799a</pub-id><pub-id pub-id-type="pmid">22218275</pub-id>
</element-citation></ref><ref id="B40-pediatrrep-17-00057"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Green</surname><given-names>R.</given-names></name>
<name><surname>Adler</surname><given-names>A.</given-names></name>
<name><surname>Banwell</surname><given-names>B.L.</given-names></name>
<name><surname>Fabri</surname><given-names>T.L.</given-names></name>
<name><surname>Yeh</surname><given-names>E.A.</given-names></name>
<name><surname>Collins</surname><given-names>D.L.</given-names></name>
<name><surname>Sled</surname><given-names>J.G.</given-names></name>
<name><surname>Narayanan</surname><given-names>S.</given-names></name>
<name><surname>Till</surname><given-names>C.</given-names></name>
</person-group><article-title>Involvement of the Amygdala in Memory and Psychosocial Functioning in Pediatric-Onset Multiple Sclerosis</article-title><source>Dev. Neuropsychol.</source><year>2018</year><volume>43</volume><fpage>524</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1080/87565641.2018.1485679</pub-id><pub-id pub-id-type="pmid">29911891</pub-id>
</element-citation></ref><ref id="B41-pediatrrep-17-00057"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cacciaguerra</surname><given-names>L.</given-names></name>
<name><surname>Curatoli</surname><given-names>C.</given-names></name>
<name><surname>Vizzino</surname><given-names>C.</given-names></name>
<name><surname>Valsasina</surname><given-names>P.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Functional correlates of cognitive abilities vary with age in pediatric multiple sclerosis</article-title><source>Mult. Scler. Relat. Disord.</source><year>2024</year><volume>82</volume><fpage>105404</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2023.105404</pub-id><pub-id pub-id-type="pmid">38159365</pub-id>
</element-citation></ref><ref id="B42-pediatrrep-17-00057"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Waubant</surname><given-names>E.</given-names></name>
<name><surname>Chabas</surname><given-names>D.</given-names></name>
<name><surname>Okuda</surname><given-names>D.T.</given-names></name>
<name><surname>Glenn</surname><given-names>O.</given-names></name>
<name><surname>Mowry</surname><given-names>E.</given-names></name>
<name><surname>Henry</surname><given-names>R.G.</given-names></name>
<name><surname>Strober</surname><given-names>J.B.</given-names></name>
<name><surname>Soares</surname><given-names>B.</given-names></name>
<name><surname>Wintermark</surname><given-names>M.</given-names></name>
<name><surname>Pelletier</surname><given-names>D.</given-names></name>
</person-group><article-title>Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults</article-title><source>Arch. Neurol.</source><year>2009</year><volume>66</volume><fpage>967</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2009.135</pub-id><pub-id pub-id-type="pmid">19667217</pub-id>
</element-citation></ref><ref id="B43-pediatrrep-17-00057"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Meo</surname><given-names>E.</given-names></name>
<name><surname>Storelli</surname><given-names>L.</given-names></name>
<name><surname>Moiola</surname><given-names>L.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Veggiotti</surname><given-names>P.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
</person-group><article-title>In vivo gradients of thalamic damage in paediatric multiple sclerosis: A window into pathology</article-title><source>Brain</source><year>2021</year><volume>144</volume><fpage>186</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1093/brain/awaa379</pub-id><pub-id pub-id-type="pmid">33221873</pub-id>
</element-citation></ref><ref id="B44-pediatrrep-17-00057"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Portaccio</surname><given-names>E.</given-names></name>
<name><surname>Goretti</surname><given-names>B.</given-names></name>
<name><surname>Lori</surname><given-names>S.</given-names></name>
<name><surname>Zipoli</surname><given-names>V.</given-names></name>
<name><surname>Centorrino</surname><given-names>S.</given-names></name>
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Patti</surname><given-names>F.</given-names></name>
<name><surname>Bianchi</surname><given-names>V.</given-names></name>
<name><surname>Comi</surname><given-names>G.</given-names></name>
<name><surname>Trojano</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>The brief neuropsychological battery for children: A screening tool for cognitive impairment in childhood and juvenile multiple sclerosis</article-title><source>Mult. Scler. J.</source><year>2009</year><volume>15</volume><fpage>620</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1177/1352458508101950</pub-id></element-citation></ref><ref id="B45-pediatrrep-17-00057"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Penner</surname><given-names>I.K.</given-names></name>
<name><surname>Raselli</surname><given-names>C.</given-names></name>
<name><surname>St&#x000f6;cklin</surname><given-names>M.</given-names></name>
<name><surname>Opwis</surname><given-names>K.</given-names></name>
<name><surname>Kappos</surname><given-names>L.</given-names></name>
<name><surname>Calabrese</surname><given-names>P.</given-names></name>
</person-group><article-title>The Fatigue Scale for Motor and Cognitive Functions (FSMC): Validation of a new instrument to assess multiple sclerosis-related fatigue</article-title><source>Mult. Scler. J.</source><year>2009</year><volume>15</volume><fpage>1509</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1177/1352458509348519</pub-id></element-citation></ref><ref id="B46-pediatrrep-17-00057"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vogt</surname><given-names>A.</given-names></name>
<name><surname>Kappos</surname><given-names>L.</given-names></name>
<name><surname>Calabrese</surname><given-names>P.</given-names></name>
<name><surname>St&#x000f6;cklin</surname><given-names>M.</given-names></name>
<name><surname>Gschwind</surname><given-names>L.</given-names></name>
<name><surname>Opwis</surname><given-names>K.</given-names></name>
<name><surname>Penner</surname><given-names>I.K.</given-names></name>
</person-group><article-title>Working memory training in patients with multiple sclerosis&#x02013;comparison of two different training schedules</article-title><source>Restor. Neurol. Neurosci.</source><year>2009</year><volume>27</volume><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.3233/RNN-2009-0473</pub-id><pub-id pub-id-type="pmid">19531877</pub-id>
</element-citation></ref><ref id="B47-pediatrrep-17-00057"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baddeley</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Working memory: Some recent developments</article-title><source>Int. J. Psychol.</source><year>2000</year><volume>35</volume><fpage>203</fpage></element-citation></ref><ref id="B48-pediatrrep-17-00057"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghezzi</surname><given-names>A.</given-names></name>
<name><surname>Deplano</surname><given-names>V.</given-names></name>
<name><surname>Faroni</surname><given-names>J.</given-names></name>
<name><surname>Grasso</surname><given-names>M.G.</given-names></name>
<name><surname>Liguori</surname><given-names>M.</given-names></name>
<name><surname>Marrosu</surname><given-names>G.</given-names></name>
<name><surname>Pozzilli</surname><given-names>C.</given-names></name>
<name><surname>Simone</surname><given-names>I.L.</given-names></name>
<name><surname>Zaffaroni</surname><given-names>M.</given-names></name>
</person-group><article-title>Multiple sclerosis in childhood: Clinical features of 149 cases</article-title><source>Mult. Scler. J.</source><year>1997</year><volume>3</volume><fpage>43</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1177/135245859700300105</pub-id></element-citation></ref><ref id="B49-pediatrrep-17-00057"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sacks</surname><given-names>D.</given-names></name>
<name><surname>Society</surname><given-names>C.P.</given-names></name>
<collab>Adolescent Health Committee</collab>
</person-group><article-title>Age limits and adolescents</article-title><source>Paediatr. Child Health</source><year>2003</year><volume>8</volume><fpage>577</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1093/pch/8.9.577</pub-id><pub-id pub-id-type="pmid">20019831</pub-id>
</element-citation></ref><ref id="B50-pediatrrep-17-00057"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mikaeloff</surname><given-names>Y.</given-names></name>
<name><surname>Suissa</surname><given-names>S.</given-names></name>
<name><surname>Vall&#x000e9;e</surname><given-names>L.</given-names></name>
<name><surname>Lubetzki</surname><given-names>C.</given-names></name>
<name><surname>Ponsot</surname><given-names>G.</given-names></name>
<name><surname>Confavreux</surname><given-names>C.</given-names></name>
<name><surname>Tardieu</surname><given-names>M.</given-names></name>
<collab>KIDMUS Study Group</collab>
</person-group><article-title>First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability</article-title><source>J. Pediatr.</source><year>2004</year><volume>144</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2003.10.056</pub-id><pub-id pub-id-type="pmid">14760270</pub-id>
</element-citation></ref><ref id="B51-pediatrrep-17-00057"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ekmekci</surname><given-names>O.</given-names></name>
</person-group><article-title>Pediatric multiple sclerosis and cognition: A review of clinical, neuropsychologic, and neuroradiologic features</article-title><source>Behav. Neurol.</source><year>2017</year><volume>2017</volume><fpage>1463570</fpage><pub-id pub-id-type="doi">10.1155/2017/1463570</pub-id><pub-id pub-id-type="pmid">29434433</pub-id>
</element-citation></ref><ref id="B52-pediatrrep-17-00057"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Julian</surname><given-names>L.</given-names></name>
<name><surname>Serafin</surname><given-names>D.</given-names></name>
<name><surname>Charvet</surname><given-names>L.</given-names></name>
<name><surname>Ackerson</surname><given-names>J.</given-names></name>
<name><surname>Benedict</surname><given-names>R.</given-names></name>
<name><surname>Braaten</surname><given-names>E.</given-names></name>
<name><surname>Brown</surname><given-names>T.</given-names></name>
<name><surname>O&#x02019;Donnell</surname><given-names>E.</given-names></name>
<name><surname>Parrish</surname><given-names>J.</given-names></name>
<name><surname>Preston</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States network</article-title><source>J. Child Neurol.</source><year>2013</year><volume>28</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1177/0883073812464816</pub-id><pub-id pub-id-type="pmid">23155206</pub-id>
</element-citation></ref><ref id="B53-pediatrrep-17-00057"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simon</surname><given-names>J.H.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Traboulsee</surname><given-names>A.</given-names></name>
<name><surname>Coyle</surname><given-names>P.K.</given-names></name>
<name><surname>Arnold</surname><given-names>D.L.</given-names></name>
<name><surname>Barkhof</surname><given-names>F.</given-names></name>
<name><surname>Frank</surname><given-names>J.A.</given-names></name>
<name><surname>Grossman</surname><given-names>R.</given-names></name>
<name><surname>Paty</surname><given-names>D.W.</given-names></name>
<name><surname>Radue</surname><given-names>E.W.</given-names></name>
<etal/>
</person-group><article-title>Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines</article-title><source>AJNR Am. J. Neuroradiol.</source><year>2006</year><volume>27</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">16484429</pub-id>
</element-citation></ref><ref id="B54-pediatrrep-17-00057"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Riva</surname><given-names>D.</given-names></name>
<name><surname>Cazzaniga</surname><given-names>F.</given-names></name>
<name><surname>Esposito</surname><given-names>S.</given-names></name>
<name><surname>Bulgheroni</surname><given-names>S.</given-names></name>
</person-group><article-title>Executive functions and cerebellar development in children</article-title><source>Appl. Neuropsychol. Child</source><year>2013</year><volume>2</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1080/21622965.2013.791092</pub-id><pub-id pub-id-type="pmid">23745837</pub-id>
</element-citation></ref><ref id="B55-pediatrrep-17-00057"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmahmann</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome</article-title><source>J. Neuropsychiatry Clin. Neurosci.</source><year>2004</year><volume>16</volume><fpage>367</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1176/jnp.16.3.367</pub-id><pub-id pub-id-type="pmid">15377747</pub-id>
</element-citation></ref><ref id="B56-pediatrrep-17-00057"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Timmann</surname><given-names>D.</given-names></name>
<name><surname>Drepper</surname><given-names>J.</given-names></name>
<name><surname>Frings</surname><given-names>M.</given-names></name>
<name><surname>Maschke</surname><given-names>M.</given-names></name>
<name><surname>Richter</surname><given-names>S.</given-names></name>
<name><surname>Gerwig</surname><given-names>M.</given-names></name>
<name><surname>Kolb</surname><given-names>F.P.</given-names></name>
</person-group><article-title>The human cerebellum contributes to motor, emotional and cognitive associative learning. A review</article-title><source>Cortex</source><year>2010</year><volume>46</volume><fpage>845</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.cortex.2009.06.009</pub-id><pub-id pub-id-type="pmid">19665115</pub-id>
</element-citation></ref><ref id="B57-pediatrrep-17-00057"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sereno</surname><given-names>M.I.</given-names></name>
<name><surname>Diedrichsen</surname><given-names>J.</given-names></name>
<name><surname>Tachrount</surname><given-names>M.</given-names></name>
<name><surname>Testa-Silva</surname><given-names>G.</given-names></name>
<name><surname>d&#x02019;Arceuil</surname><given-names>H.</given-names></name>
<name><surname>De Zeeuw</surname><given-names>C.</given-names></name>
</person-group><article-title>The human cerebellum has almost 80% of the surface area of the neocortex</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>19538</fpage><lpage>19543</lpage><pub-id pub-id-type="doi">10.1073/pnas.2002896117</pub-id><pub-id pub-id-type="pmid">32723827</pub-id>
</element-citation></ref><ref id="B58-pediatrrep-17-00057"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rondi-Reig</surname><given-names>L.</given-names></name>
<name><surname>Paradis</surname><given-names>A.L.</given-names></name>
<name><surname>Fallahnezhad</surname><given-names>M.</given-names></name>
</person-group><article-title>A liaison brought to light: Cerebellum-hippocampus, partners for spatial cognition</article-title><source>Cerebellum</source><year>2022</year><volume>21</volume><fpage>826</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1007/s12311-022-01422-3</pub-id><pub-id pub-id-type="pmid">35752720</pub-id>
</element-citation></ref><ref id="B59-pediatrrep-17-00057"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tedesco</surname><given-names>A.M.</given-names></name>
<name><surname>Chiricozzi</surname><given-names>F.R.</given-names></name>
<name><surname>Clausi</surname><given-names>S.</given-names></name>
<name><surname>Lupo</surname><given-names>M.</given-names></name>
<name><surname>Molinari</surname><given-names>M.</given-names></name>
<name><surname>Leggio</surname><given-names>M.G.</given-names></name>
</person-group><article-title>The cerebellar cognitive profile</article-title><source>Brain</source><year>2011</year><volume>134</volume><fpage>3672</fpage><lpage>3686</lpage><pub-id pub-id-type="doi">10.1093/brain/awr266</pub-id><pub-id pub-id-type="pmid">22036960</pub-id>
</element-citation></ref><ref id="B60-pediatrrep-17-00057"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tervo-Clemmens</surname><given-names>B.</given-names></name>
<name><surname>Calabro</surname><given-names>F.J.</given-names></name>
<name><surname>Parr</surname><given-names>A.C.</given-names></name>
<name><surname>Fedor</surname><given-names>J.</given-names></name>
<name><surname>Foran</surname><given-names>W.</given-names></name>
<name><surname>Luna</surname><given-names>B.</given-names></name>
</person-group><article-title>A canonical trajectory of executive function maturation from adolescence to adulthood</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>6922</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42540-8</pub-id><pub-id pub-id-type="pmid">37903830</pub-id>
</element-citation></ref><ref id="B61-pediatrrep-17-00057"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiemeier</surname><given-names>H.</given-names></name>
<name><surname>Lenroot</surname><given-names>R.K.</given-names></name>
<name><surname>Greenstein</surname><given-names>D.K.</given-names></name>
<name><surname>Tran</surname><given-names>L.</given-names></name>
<name><surname>Pierson</surname><given-names>R.</given-names></name>
<name><surname>Giedd</surname><given-names>J.N.</given-names></name>
</person-group><article-title>Cerebellum development during childhood and adolescence: A longitudinal morphometric MRI study</article-title><source>Neuroimage</source><year>2010</year><volume>49</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.08.016</pub-id><pub-id pub-id-type="pmid">19683586</pub-id>
</element-citation></ref><ref id="B62-pediatrrep-17-00057"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yassa</surname><given-names>M.A.</given-names></name>
<name><surname>Stark</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Pattern separation in the hippocampus</article-title><source>Trends Neurosci.</source><year>2011</year><volume>34</volume><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2011.06.006</pub-id><pub-id pub-id-type="pmid">21788086</pub-id>
</element-citation></ref><ref id="B63-pediatrrep-17-00057"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iglesias</surname><given-names>J.E.</given-names></name>
<name><surname>Augustinack</surname><given-names>J.C.</given-names></name>
<name><surname>Nguyen</surname><given-names>K.</given-names></name>
<name><surname>Player</surname><given-names>C.M.</given-names></name>
<name><surname>Player</surname><given-names>A.</given-names></name>
<name><surname>Wright</surname><given-names>M.</given-names></name>
<name><surname>Roy</surname><given-names>N.</given-names></name>
<name><surname>Frosch</surname><given-names>M.P.</given-names></name>
<name><surname>McKee</surname><given-names>A.C.</given-names></name>
<name><surname>Wald</surname><given-names>L.L.</given-names></name>
<etal/>
</person-group><article-title>A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI</article-title><source>Neuroimage</source><year>2015</year><volume>115</volume><fpage>117</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.04.042</pub-id><pub-id pub-id-type="pmid">25936807</pub-id>
</element-citation></ref><ref id="B64-pediatrrep-17-00057"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mu</surname><given-names>S.H.</given-names></name>
<name><surname>Yuan</surname><given-names>B.K.</given-names></name>
<name><surname>Tan</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Effect of Gender on Development of Hippocampal Subregions From Childhood to Adulthood</article-title><source>Front. Hum. Neurosci.</source><year>2020</year><volume>14</volume><elocation-id>611057</elocation-id><pub-id pub-id-type="doi">10.3389/fnhum.2020.611057</pub-id><pub-id pub-id-type="pmid">33343321</pub-id>
</element-citation></ref><ref id="B65-pediatrrep-17-00057"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>M.A.</given-names></name>
<name><surname>Barkhof</surname><given-names>F.</given-names></name>
<name><surname>De Luca</surname><given-names>J.</given-names></name>
<name><surname>Fris&#x000e9;n</surname><given-names>J.</given-names></name>
<name><surname>Geurts</surname><given-names>J.J.</given-names></name>
<name><surname>Hulst</surname><given-names>H.E.</given-names></name>
<name><surname>Sastre-Garriga</surname><given-names>J.</given-names></name>
<name><surname>Filippi</surname><given-names>M.</given-names></name>
<name><surname>Yousry</surname><given-names>T.A.</given-names></name>
</person-group><article-title>The hippocampus in multiple sclerosis</article-title><source>Lancet Neurol.</source><year>2018</year><volume>17</volume><fpage>918</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(18)30309-0</pub-id><pub-id pub-id-type="pmid">30264730</pub-id>
</element-citation></ref><ref id="B66-pediatrrep-17-00057"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wierenga</surname><given-names>L.</given-names></name>
<name><surname>Langen</surname><given-names>M.</given-names></name>
<name><surname>Ambrosino</surname><given-names>S.</given-names></name>
<name><surname>van Dijk</surname><given-names>S.</given-names></name>
<name><surname>Oranje</surname><given-names>B.</given-names></name>
<name><surname>Durston</surname><given-names>S.</given-names></name>
</person-group><article-title>Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24</article-title><source>Neuroimage</source><year>2014</year><volume>96</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.03.072</pub-id><pub-id pub-id-type="pmid">24705201</pub-id>
</element-citation></ref><ref id="B67-pediatrrep-17-00057"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>LaBerge</surname><given-names>D.</given-names></name>
<name><surname>Buchsbaum</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Positron emission tomographic measurements of pulvinar activity during an attention task</article-title><source>J. Neurosci.</source><year>1990</year><volume>10</volume><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.10-02-00613.1990</pub-id><pub-id pub-id-type="pmid">2303863</pub-id>
</element-citation></ref><ref id="B68-pediatrrep-17-00057"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Minagar</surname><given-names>A.</given-names></name>
<name><surname>Barnett</surname><given-names>M.H.</given-names></name>
<name><surname>Benedict</surname><given-names>R.H.</given-names></name>
<name><surname>Pelletier</surname><given-names>D.</given-names></name>
<name><surname>Pirko</surname><given-names>I.</given-names></name>
<name><surname>Sahraian</surname><given-names>M.A.</given-names></name>
<name><surname>Frohman</surname><given-names>E.</given-names></name>
<name><surname>Zivadinov</surname><given-names>R.</given-names></name>
</person-group><article-title>The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects</article-title><source>Neurology</source><year>2013</year><volume>80</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31827b910b</pub-id><pub-id pub-id-type="pmid">23296131</pub-id>
</element-citation></ref><ref id="B69-pediatrrep-17-00057"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harrison</surname><given-names>D.M.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
<name><surname>Roy</surname><given-names>S.</given-names></name>
<name><surname>Wood</surname><given-names>E.T.</given-names></name>
<name><surname>Whetstone</surname><given-names>A.</given-names></name>
<name><surname>Seigo</surname><given-names>M.A.</given-names></name>
<name><surname>Jones</surname><given-names>C.K.</given-names></name>
<name><surname>Pham</surname><given-names>D.</given-names></name>
<name><surname>van Zijl</surname><given-names>P.</given-names></name>
<name><surname>Reich</surname><given-names>D.S.</given-names></name>
<etal/>
</person-group><article-title>Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology</article-title><source>Mult. Scler. J.</source><year>2015</year><volume>21</volume><fpage>1139</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1177/1352458514558134</pub-id></element-citation></ref><ref id="B70-pediatrrep-17-00057"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rushworth</surname><given-names>M.F.</given-names></name>
<name><surname>Buckley</surname><given-names>M.J.</given-names></name>
<name><surname>Behrens</surname><given-names>T.E.</given-names></name>
<name><surname>Walton</surname><given-names>M.E.</given-names></name>
<name><surname>Bannerman</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Functional organization of the medial frontal cortex</article-title><source>Curr. Opin. Neurobiol.</source><year>2007</year><volume>17</volume><fpage>220</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2007.03.001</pub-id><pub-id pub-id-type="pmid">17350820</pub-id>
</element-citation></ref><ref id="B71-pediatrrep-17-00057"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Margulies</surname><given-names>D.S.</given-names></name>
<name><surname>Kelly</surname><given-names>A.C.</given-names></name>
<name><surname>Uddin</surname><given-names>L.Q.</given-names></name>
<name><surname>Biswal</surname><given-names>B.B.</given-names></name>
<name><surname>Castellanos</surname><given-names>F.X.</given-names></name>
<name><surname>Milham</surname><given-names>M.P.</given-names></name>
</person-group><article-title>Mapping the functional connectivity of anterior cingulate cortex</article-title><source>Neuroimage</source><year>2007</year><volume>37</volume><fpage>579</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.05.019</pub-id><pub-id pub-id-type="pmid">17604651</pub-id>
</element-citation></ref><ref id="B72-pediatrrep-17-00057"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van den Heuvel</surname><given-names>M.P.</given-names></name>
<name><surname>Hulshoff Pol</surname><given-names>H.E.</given-names></name>
</person-group><article-title>Exploring the brain network: A review on resting-state fMRI functional connectivity</article-title><source>Eur. Neuropsychopharmacol.</source><year>2010</year><volume>20</volume><fpage>519</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2010.03.008</pub-id><pub-id pub-id-type="pmid">20471808</pub-id>
</element-citation></ref><ref id="B73-pediatrrep-17-00057"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shenhav</surname><given-names>A.</given-names></name>
<name><surname>Cohen</surname><given-names>J.D.</given-names></name>
<name><surname>Botvinick</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Dorsal anterior cingulate cortex and the value of control</article-title><source>Nat. Neurosci.</source><year>2016</year><volume>19</volume><fpage>1286</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1038/nn.4384</pub-id><pub-id pub-id-type="pmid">27669989</pub-id>
</element-citation></ref><ref id="B74-pediatrrep-17-00057"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cera</surname><given-names>N.</given-names></name>
<name><surname>Esposito</surname><given-names>R.</given-names></name>
<name><surname>Cieri</surname><given-names>F.</given-names></name>
<name><surname>Tartaro</surname><given-names>A.</given-names></name>
</person-group><article-title>Altered cingulate cortex functional connectivity in normal aging and mild cognitive impairment</article-title><source>Front. Neurosci.</source><year>2019</year><volume>13</volume><elocation-id>857</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2019.00857</pub-id><pub-id pub-id-type="pmid">31572106</pub-id>
</element-citation></ref><ref id="B75-pediatrrep-17-00057"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Han</surname><given-names>S.W.</given-names></name>
<name><surname>Eaton</surname><given-names>H.P.</given-names></name>
<name><surname>Marois</surname><given-names>R.</given-names></name>
</person-group><article-title>Functional fractionation of the cingulo-opercular network: Alerting insula and updating cingulate</article-title><source>Cereb. Cortex</source><year>2019</year><volume>29</volume><fpage>2624</fpage><lpage>2638</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhy130</pub-id><pub-id pub-id-type="pmid">29850839</pub-id>
</element-citation></ref><ref id="B76-pediatrrep-17-00057"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silveira</surname><given-names>S.</given-names></name>
<name><surname>Boney</surname><given-names>S.</given-names></name>
<name><surname>Tapert</surname><given-names>S.F.</given-names></name>
<name><surname>Mishra</surname><given-names>J.</given-names></name>
</person-group><article-title>Developing functional network connectivity of the dorsal anterior cingulate cortex mediates externalizing psychopathology in adolescents with child neglect</article-title><source>Dev. Cogn. Neurosci.</source><year>2021</year><volume>49</volume><fpage>100962</fpage><pub-id pub-id-type="doi">10.1016/j.dcn.2021.100962</pub-id><pub-id pub-id-type="pmid">34015723</pub-id>
</element-citation></ref><ref id="B77-pediatrrep-17-00057"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Power</surname><given-names>J.D.</given-names></name>
<name><surname>Cohen</surname><given-names>A.L.</given-names></name>
<name><surname>Nelson</surname><given-names>S.M.</given-names></name>
<name><surname>Wig</surname><given-names>G.S.</given-names></name>
<name><surname>Barnes</surname><given-names>K.A.</given-names></name>
<name><surname>Church</surname><given-names>J.A.</given-names></name>
<name><surname>Vogel</surname><given-names>A.C.</given-names></name>
<name><surname>Laumann</surname><given-names>T.O.</given-names></name>
<name><surname>Miezin</surname><given-names>F.M.</given-names></name>
<name><surname>Schlaggar</surname><given-names>B.L.</given-names></name>
<etal/>
</person-group><article-title>Functional network organization of the human brain</article-title><source>Neuron</source><year>2011</year><volume>72</volume><fpage>665</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.006</pub-id><pub-id pub-id-type="pmid">22099467</pub-id>
</element-citation></ref><ref id="B78-pediatrrep-17-00057"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simmonds</surname><given-names>D.J.</given-names></name>
<name><surname>Hallquist</surname><given-names>M.N.</given-names></name>
<name><surname>Asato</surname><given-names>M.</given-names></name>
<name><surname>Luna</surname><given-names>B.</given-names></name>
</person-group><article-title>Developmental stages and sex differences of white matter and behavioral development through adolescence: A longitudinal diffusion tensor imaging (DTI) study</article-title><source>Neuroimage</source><year>2014</year><volume>92</volume><fpage>356</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.12.044</pub-id><pub-id pub-id-type="pmid">24384150</pub-id>
</element-citation></ref><ref id="B79-pediatrrep-17-00057"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Petanjek</surname><given-names>Z.</given-names></name>
<name><surname>Juda&#x00161;</surname><given-names>M.</given-names></name>
<name><surname>&#x00160;imi&#x00107;</surname><given-names>G.</given-names></name>
<name><surname>Ra&#x00161;in</surname><given-names>M.R.</given-names></name>
<name><surname>Uylings</surname><given-names>H.B.</given-names></name>
<name><surname>Rakic</surname><given-names>P.</given-names></name>
<name><surname>Kostovi&#x00107;</surname><given-names>I.</given-names></name>
</person-group><article-title>Extraordinary neoteny of synaptic spines in the human prefrontal cortex</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>13281</fpage><lpage>13286</lpage><pub-id pub-id-type="doi">10.1073/pnas.1105108108</pub-id><pub-id pub-id-type="pmid">21788513</pub-id>
</element-citation></ref><ref id="B80-pediatrrep-17-00057"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Faustino</surname><given-names>R.</given-names></name>
<name><surname>Lopes</surname><given-names>C.</given-names></name>
<name><surname>Jantarada</surname><given-names>A.</given-names></name>
<name><surname>Mendon&#x000e7;a</surname><given-names>A.</given-names></name>
<name><surname>Raposo</surname><given-names>R.</given-names></name>
<name><surname>Ferr&#x000e3;o</surname><given-names>C.</given-names></name>
<name><surname>Freitas</surname><given-names>J.</given-names></name>
<name><surname>Mateus</surname><given-names>C.</given-names></name>
<name><surname>Pinto</surname><given-names>A.</given-names></name>
<name><surname>Almeida</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Neuroimaging characterization of multiple sclerosis lesions in pediatric patients: An exploratory radiomics approach</article-title><source>Front. Neurosci.</source><year>2024</year><volume>18</volume><elocation-id>1294574</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2024.1294574</pub-id><pub-id pub-id-type="pmid">38370435</pub-id>
</element-citation></ref><ref id="B81-pediatrrep-17-00057"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raichle</surname><given-names>M.E.</given-names></name>
</person-group><article-title>The restless brain</article-title><source>Brain Connect.</source><year>2011</year><volume>1</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1089/brain.2011.0019</pub-id><pub-id pub-id-type="pmid">22432951</pub-id>
</element-citation></ref><ref id="B82-pediatrrep-17-00057"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raichle</surname><given-names>M.E.</given-names></name>
</person-group><article-title>The brain&#x02019;s default mode network</article-title><source>Annu. Rev. Neurosci.</source><year>2015</year><volume>38</volume><fpage>433</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014030</pub-id><pub-id pub-id-type="pmid">25938726</pub-id>
</element-citation></ref><ref id="B83-pediatrrep-17-00057"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buckner</surname><given-names>R.L.</given-names></name>
<name><surname>Carroll</surname><given-names>D.C.</given-names></name>
</person-group><article-title>Self-projection and the brain</article-title><source>Trends Cogn. Sci.</source><year>2007</year><volume>11</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2006.11.004</pub-id><pub-id pub-id-type="pmid">17188554</pub-id>
</element-citation></ref><ref id="B84-pediatrrep-17-00057"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schilbach</surname><given-names>L.</given-names></name>
<name><surname>Eickhoff</surname><given-names>S.B.</given-names></name>
<name><surname>Rotarska-Jagiela</surname><given-names>A.</given-names></name>
<name><surname>Fink</surname><given-names>G.R.</given-names></name>
<name><surname>Vogeley</surname><given-names>K.</given-names></name>
</person-group><article-title>Minds at rest? Social cognition as the default mode of cognizing and its putative relationship to the &#x0201c;default system&#x0201d; of the brain</article-title><source>Conscious Cogn.</source><year>2008</year><volume>17</volume><fpage>457</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.concog.2008.03.013</pub-id><pub-id pub-id-type="pmid">18434197</pub-id>
</element-citation></ref><ref id="B85-pediatrrep-17-00057"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Br&#x000fc;ne</surname><given-names>M.</given-names></name>
<name><surname>Br&#x000fc;ne-Cohrs</surname><given-names>U.</given-names></name>
</person-group><article-title>Theory of mind&#x02014;Evolution, ontogeny, brain mechanisms and psychopathology</article-title><source>Neurosci. Biobehav. Rev.</source><year>2006</year><volume>30</volume><fpage>437</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2005.08.001</pub-id><pub-id pub-id-type="pmid">16239031</pub-id>
</element-citation></ref><ref id="B86-pediatrrep-17-00057"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Charvet</surname><given-names>L.E.</given-names></name>
<name><surname>Cleary</surname><given-names>R.E.</given-names></name>
<name><surname>Vazquez</surname><given-names>K.</given-names></name>
<name><surname>Belman</surname><given-names>A.L.</given-names></name>
<name><surname>Krupp</surname><given-names>L.B.</given-names></name>
<name><surname>USNetwork for Pediatric</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Social cognition in pediatric-onset multiple sclerosis (MS)</article-title><source>Mult. Scler. J.</source><year>2014</year><volume>20</volume><fpage>1478</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1177/1352458514526942</pub-id></element-citation></ref><ref id="B87-pediatrrep-17-00057"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Isernia</surname><given-names>S.</given-names></name>
<name><surname>Rossetto</surname><given-names>F.</given-names></name>
<name><surname>Castelli</surname><given-names>F.</given-names></name>
<name><surname>Rovaris</surname><given-names>M.</given-names></name>
<name><surname>Blasi</surname><given-names>V.</given-names></name>
<name><surname>Baglio</surname><given-names>F.</given-names></name>
</person-group><article-title>Beyond the simplicity of theory of mind deficit in multiple sclerosis: From kinetic perception to socio-emotional abstraction and mentalizing</article-title><source>Mult. Scler. Relat. Disord.</source><year>2023</year><volume>77</volume><fpage>104894</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2023.104894</pub-id><pub-id pub-id-type="pmid">37490809</pub-id>
</element-citation></ref><ref id="B88-pediatrrep-17-00057"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Massano</surname><given-names>C.</given-names></name>
<name><surname>Lima</surname><given-names>M.</given-names></name>
<name><surname>Monteiro</surname><given-names>I.</given-names></name>
<name><surname>Machado</surname><given-names>R.</given-names></name>
<name><surname>Correia</surname><given-names>I.</given-names></name>
<name><surname>Nunes</surname><given-names>C.C.</given-names></name>
<name><surname>Mac&#x000e1;rio</surname><given-names>C.</given-names></name>
<name><surname>Sousa</surname><given-names>L.</given-names></name>
<name><surname>Santana</surname><given-names>I.</given-names></name>
<name><surname>Batista</surname><given-names>S.</given-names></name>
</person-group><article-title>Outcomes on Social and Classic Cognition in adults with Pediatric-onset Multiple Sclerosis</article-title><source>Mult. Scler. Relat. Disord.</source><year>2021</year><volume>53</volume><fpage>103071</fpage><pub-id pub-id-type="doi">10.1016/j.msard.2021.103071</pub-id><pub-id pub-id-type="pmid">34161899</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="pediatrrep-17-00057-f001"><label>Figure 1</label><caption><p>Flowchart of the selection process. <italic toggle="yes">From:</italic> Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71 [<xref rid="B14-pediatrrep-17-00057" ref-type="bibr">14</xref>]. For more information, visit <uri xlink:href="http://www.prisma-statement.org/">http://www.prisma-statement.org/</uri> (accessed on 12 March 2024).</p></caption><graphic xlink:href="pediatrrep-17-00057-g001" position="float"/></fig><fig position="float" id="pediatrrep-17-00057-f002"><label>Figure 2</label><caption><p>ALE fMRI meta-analysis map results of the included pediatric MS studies. ALE map of the resulting clusters for fMRI studies on pediatric multiple sclerosis. Maps are overimposed on a 2 &#x000d7; 2 &#x000d7; 2 mm MNI template according to neurological conventions. (<bold>a</bold>) The map denotes the cluster corresponding to the left supplementary motor area (SMA); the map in (<bold>b</bold>) includes the cluster corresponding to the dorsal anterior cingulate cortex (dACC); the map depicted in (<bold>c</bold>) denotes the clusters corresponding to the left and right angular gyri; and (<bold>d</bold>) shows the cluster corresponding to the right superior parietal lobe (SPL). The colored bar denotes the corresponding ALE value ranges indicated on the maps (<italic toggle="yes">p</italic> &#x0003c; 0.0005).</p></caption><graphic xlink:href="pediatrrep-17-00057-g002" position="float"/></fig><table-wrap position="float" id="pediatrrep-17-00057-t001"><object-id pub-id-type="pii">pediatrrep-17-00057-t001_Table 1</object-id><label>Table 1</label><caption><p>Inclusion and exclusion criteria for the selected studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inclusion Criteria</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Exclusion Criteria</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Design</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Experimental studies <break/> Case&#x02013;control studies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other designs <break/> Systematic reviews</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Population</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children <break/> Adolescents</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Animals <break/> Adults</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Intervention</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuroimaging techniques <break/> Emotional task <break/> Cognitive task <break/> Resting state <break/> Structural MRI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EEG <break/> Other imaging techniques</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Topic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brain activation <break/> Brain activity <break/> Brain connectivity <break/> Gray matter alteration</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brain activation, brain activity, brain connectivity, and gray matter alteration in adult MS patients or adult MS patients with pediatric-onset</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: MRI = magnetic resonance imaging; EEG = electroencephalography; MS = multiple sclerosis.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pediatrrep-17-00057-t002"><object-id pub-id-type="pii">pediatrrep-17-00057-t002_Table 2</object-id><label>Table 2</label><caption><p>Newcastle&#x02013;Ottawa quality assessment scale: case&#x02013;control studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hits</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Selection</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comparability</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Exposure</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aubert Broche et al., 2011 [<xref rid="B23-pediatrrep-17-00057" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cirillo et al., 2016 [<xref rid="B24-pediatrrep-17-00057" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2009 [<xref rid="B25-pediatrrep-17-00057" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">De Meo et al., 2017 [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fuentes et al., 2012 [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2010 [<xref rid="B28-pediatrrep-17-00057" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2016 [<xref rid="B30-pediatrrep-17-00057" ref-type="bibr">30</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rocca et al., 2016 [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ceccarelli et al., 2011 [<xref rid="B33-pediatrrep-17-00057" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bartels et al., 2019 [<xref rid="B34-pediatrrep-17-00057" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">De Meo et al., 2021 [<xref rid="B35-pediatrrep-17-00057" ref-type="bibr">35</xref>] </td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hubacher et al., 2015 [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Margoni et al., 2020 [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">*</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Weier et al., 2016 [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Kerbrat et al., 2012 [<xref rid="B39-pediatrrep-17-00057" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Green et al., 2018 [<xref rid="B40-pediatrrep-17-00057" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">****</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cacciaguerra et al., 2024 [<xref rid="B41-pediatrrep-17-00057" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Waubant et al., 2009 [<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">**</td><td align="center" valign="middle" rowspan="1" colspan="1">***</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Meo et al., 2021 [<xref rid="B43-pediatrrep-17-00057" ref-type="bibr">43</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">***</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">**</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">***</td></tr></tbody></table><table-wrap-foot><fn><p>Note: A study can be awarded a maximum of four stars (****) for the selection category and three stars (***) for the exposure category. A maximum of two stars (**) can be given for comparability.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pediatrrep-17-00057-t003"><object-id pub-id-type="pii">pediatrrep-17-00057-t003_Table 3</object-id><label>Table 3</label><caption><p>Principal characteristics and results of the included studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N/Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Neurological Assessment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Magnetic Field/MRI Sequence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Analytical Techniques</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tasks</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Lesion Volume</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Principal Results</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aubert&#x02014;Broche et al., 2011 [<xref rid="B23-pediatrrep-17-00057" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS RR: N = 30 (24 girls); mean age = 15.4 &#x000b1; 2.1 years. <break/> HCs: N = 29 (23 girls); mean age = 15.5 &#x000b1; 2 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1 (0.0&#x02013;4.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRI; 1.5 T; 3D T1w RF-spoiled gradient-recalled echo sequence; <break/> 2D multislice proton density-weighted (PDw)/T2w fast spin echo sequence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preprocessing, spatial <break/> normalization, and Jacobian calculation <break/> GLM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Median 3303 mm<sup>3</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant volume loss in the MS group in the pulvinar, right anterior nuclei, splenium of the corpus callosum, and globus pallidus. Volume expansion significant in the foramen of Monroe and left lateral ventricle. <break/> Regression against disease duration showed significantly correlated volume reductions in the left and right globus pallidus and within the optic tract, from the optic chiasm to the lateral geniculate nucleus and anterior part of the optic radiations</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ceccarelli et al., 2011 [<xref rid="B24-pediatrrep-17-00057" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 CIS and 35 RRMS (27 girls and 18 boys); mean age (SD) 14.7 (2.4) years. 14 HCs (7 girls and 7 boys); mean age (SD) 16.4 (4.7) years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.0 (0.0&#x02013;6.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 T; <break/> dual-echo turbo SE <break/> TR = 3300 ms, TE = 16/98 ms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T2 intensity in deep gray matter structures</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (ml) = 5.2 SD = 7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T2 intensity of the head of the left caudate nucleus differed between pediatric MS patients and HCs (<italic toggle="yes">p</italic> = 0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fuentes et al., 2012 [<xref rid="B27-pediatrrep-17-00057" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediatric MS: N = 32 (25 girls); age 16.3. <break/> HCs: N = 26 (21 girls); age = 16.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.0 (0.0&#x02013;4.0); neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5T <break/> 3D T1-weighted <break/> radiofrequency-spoiled gradient-recalled echo sequence with <break/> 1.5 mm thick sagittal partitions, TR = 22 ms, TE = 8 ms. 2D multislice proton density-weighted <break/> /T2-weighted fast spin echo sequence with an echo train <break/> Length = 58, TR: 3500 ms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Segmentation of brain structures. ANOVA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Log T2-LV total brain mean = 3.68 SD = 0.54</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients &#x0003e; HCs = Lower whole brain volume <break/> Lower normalized volumes in the amygdala (total and left side) and thalamus (left, right, and total)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B29-pediatrrep-17-00057" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediatric RRMS CP patients: N = 35 (21 girls); age = 15.4. <break/> Pediatric RRMS CI patients: N = 16 (9 girls); age = 15.2. <break/> HCs: N = 16 (9 girls); age = 14.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (0&#x02013;3.5), <break/> neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T <break/> fMRI:T2*-weighted single-shot EPI; dual-echo turbo SE; 3D T1-weighted <break/> FFE; and pulsed-gradient SE EPI with diffusion gradients applied in 35 noncollinear directions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Functional connectivity analysis. Segmentation. Voxel brain morphometry,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 4.8 SD = 6.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CI patients had an increased probability of harboring lesions in the right thalamus, middle and posterior cingulate cortex, and bilateral parieto-occipital white matter. GM atrophy: CI patients had atrophy of the right precuneus and left middle temporal gyrus. <break/> MS patients had decreased FC of the posterior regions of the DMN (Right precuneus). CP patients vs. HCs had decreased RS FC of the right angular gyrus. CI patients vs. both HCs and CP patients had decreased RS FC of the right precuneus. CP patients experienced an increased RS FC of the anterior cingulate cortex</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2014 [<xref rid="B31-pediatrrep-17-00057" ref-type="bibr">31</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS CP: N = 28 (19 girls); age = 14.9. <break/> MS CI: N = 16 (9 girls); age = 15.7. <break/> HCs: N = 27; females: 16; age = 15.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (0.0&#x02013;4.0), neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T <break/> fMRI: T-2 *W single-shot EPI: TR = 3000 ms, TE = 35 ms. Dual-echo turbo <break/> SE. 3D-T1-W FFE. Pulsed-gradient SE <break/> EPI, 35 noncollinear direction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Independent component analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 4.8 SD = 6.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to HCs, MS patients showed increased FC between the sensorimotor II network and the DMN and between the WMN and the attention network. They also showed a decreased FC between the WMN and the DMN. The decreased FC between WMN and DMN was corrected for GM atrophy. No differences in FC were found between CP and CI MS patients.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Weier et al., 2016 [<xref rid="B38-pediatrrep-17-00057" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 28 (21 girls); age = 16.3 &#x000b1; 2.2. HCs: N = 33 (26 girls); age = 15.5 &#x000b1; 2.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS Median: 1.25 (0&#x02013;4); neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5T <break/> 3D T1-W RF-spoiled gradient-recalled echo; 2D proton density-T2-W fast SE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Segmentation of the human cerebellum and its lobules, combining patch-based label fusion and a template library of manually labeled cerebella of the controls</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebellar lesion <break/> (infratentorial): Median 0.1 (0&#x02013;4.4) <break/> Supratentorial lesion: Median: 4.6 (0.3&#x02013;35.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebral volume was reduced in MS patients. Cerebellar volumes did not differ. Correlation between cerebellar volume and neuropsychological results</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hubacher et al., 2015 [<xref rid="B36-pediatrrep-17-00057" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 patients between 12 and 18 yrs. Case series study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = NA; neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T; MPRAGE; FLAIR; fMRI: EPI&#x02014;TR/TE = 2000/23 ms,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GLM; FC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-back</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL): Case 1 = 4.2; Case 2 = 5.3; Case 3 = 5.9; Case 4 = 0.85; Case 5 = 9.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FC between the ventral and the dorsal DMN increased in 2 patients. No differences in the other patients</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cirillo et al., 2016 [<xref rid="B24-pediatrrep-17-00057" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RRMS: N = 48; (31 girls); age: 14.9. <break/> CP MS: N = 39 (22 girls); age: 14.9. <break/> CI MS: N = 8 (5 girls); age: 15.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS: Median: 1.5 (0&#x02013;4.0) <break/> 9-HPT: nine-hole peg test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T. fMRI: EPI-TR = 3000 ms, TE = 35 ms; dual-echo turbo spin echo TR/ <break/> TE = 2599/16.80 ms. MRI: T1-weighted FFE TR = 25 ms, <break/> TE = 4.6 ms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resting state; <break/> seed-based FC; seeds: left and right dentate nucleus of the cerebellum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 5.3 SD = 6.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In MS infratentorial, the T2 lesion volume was approximately 10% of the total T2 lesion volume. <break/> Compared with controls, MS patients also showed an increased rest FC between the bilateral dentate nucleus and the left pre- and postcentral gyri</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2016 [<xref rid="B30-pediatrrep-17-00057" ref-type="bibr">30</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients: N = 11 (9 girls); age = 11.1. <break/> HCs: N = 13 (11 girls); age = 12.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.0 (0&#x02013;3.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 T, dual-echo fast SE TR = 3500 ms, TE = 15/63 ms. 3D <break/> T1-W TR = 22 ms, TE = 8 ms, pulsed gradient spin echo single-shot echo planar imaging, 25 noncollinear directions.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FA and MD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 2.5 SD = 4.7 <break/> Mean (mL) = 7.1 SD = 3.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients had significantly reduced FA and increased MD in the left and right superior longitudinal fasciculus and corpus callosum</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca et al., 2016 [<xref rid="B32-pediatrrep-17-00057" ref-type="bibr">32</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS CP: N = 41 (26 girls); age = 15.1. <break/> MS CI N = 12 (6 girls), age = 15.0. <break/> HCs: N = 18 (10 girls); age = 14.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (0.0&#x02013;4.0); neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T; brain dual-echo, <break/> turbo SE, and brain 3D T1-weighted FFE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radial mapping analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 6.3 SD = 7.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Global hippocampal volume was reduced in MS patients compared to HCs. Compared to HCs, MS patients showed atrophy of the cornu ammonis, subiculum, and dentate gyrus subfields and radial hypertrophy of the dentate gyrus subfield. Regional hippocampal volume modifications correlated with brain T2 lesion volume, attention, and language abilities. Compared to CP patients, CI patients had atrophy of the right subiculum and dentate gyrus subfields</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Meo et al., 2017 [<xref rid="B26-pediatrrep-17-00057" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS CP: N = 44 (30 girls); age: 15.2. <break/> MS CI: N = 13 (6 girls); age: 15.1. <break/> HCs: N = 14 (8 girls); age: 13.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS: Median: 1.0 (0.0&#x02013;4.0); neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T2*-weighted single-shot echo-planar imaging scan during the task; DT MRI scan, dual-echo turbo spin echo scan, and 3-dimensional T1-weighted FFE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GLM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCPT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean (mL) = 6.0 SD = 7.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CI vs. CP patients: lower normalized brain volume, lower WM volume, and lower FA values in the tracts connecting the left anterior insula to the anterior cingulate cortex (ACC) and precuneus. <break/> CCPT load condition: CP patients &#x0003e; HCs. Increased activation of the left anterior insula and thalamus and decreased deactivation of the ACC and right inferior frontal gyrus. Increased deactivation of the right precuneus and superior parietal lobule. CI &#x0003e; CP patients decreased activation of the right postcentral gyrus and increased deactivation of bilateral precuneus. CP &#x0003e; CI patients with pediatric MS had increased activity in the parietal and occipital lobes and cerebellum. <break/> No significant correlations</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bartels et al., 2019 [<xref rid="B34-pediatrrep-17-00057" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 37 (18 girls); age = 15; multicenter study&#x02014;2-year follow-up</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 0(0&#x02013;2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T; 3D T1-weighted (MPRAGE)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total lesion count: median = 4; range = 1&#x02013;10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients: significant brain volume loss, GM, and WM volume associated with increased ventricular volume at the first clinical presentation. Patients continue to have further brain volume loss at follow-up (2 years).</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Meo et al., 2021 [<xref rid="B35-pediatrrep-17-00057" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 123 (brain MRI); N = 115 (cervical cord MRI); 89 girls; age: 14.4 yr. 1-year and 2-year follow-ups</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (0.0&#x02013;6.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 T; BRAIN: FLAIR T2-W, and/or CERVICAL CORD: STIR, T2-W <break/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nr of T2 lesions: mean (range): 30.5 (3&#x02013;180)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Optic neuritis was observed in 74% of patients. No significant differences in demographic, clinical, and MRI features were observed. Significant nr. of lesions at the brain stem and cervical cord (baseline); 1 yr follow-up: no significant nr. of lesions vs. baseline; 2 yr follow-up: significant nr. of new lesions.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Margoni et al., 2020 [<xref rid="B37-pediatrrep-17-00057" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS = 15 (12 girls); age = 14.1 &#x000b1; 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (IQR: 1.0&#x02013;2.25); neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 T; DIR = resolution <break/> 1 &#x000d7; 1 &#x000d7; 3 mm, FOV 230 &#x000d7; 200 mm, TR 13,000 ms, TE 10 ms, <break/> TI 3400/325 ms, slices n40, time 3.5 min; PSIR: resolution <break/> 1 &#x000d7; 1 &#x000d7; 3 mm, FOV 230 &#x000d7; 200 mm, TR 7000 ms, TE 13 ms, <break/> TI 400 ms, slices = 40, and time 7 min.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DIR WM lesion, mean nr = 1; PSIR WML, mean nr = 1.6; DIR cortical L, mean nr = 1.1; <break/> PSIR cortical mean: nr = 2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WM and/or GM lesions were found in the cerebellum in patients. PSIR allowed the identification of a significantly higher number of GM lesions than DIR. Patients had no symptoms of cerebellar dysfunction. The number of supratentorial lesions did not correlate with the number of cerebellar lesions</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Meo, 2021 [<xref rid="B43-pediatrrep-17-00057" ref-type="bibr">43</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 70 (44 girls); median age = 15.6. <break/> HCs: N = 26 (16 girls); median age = 15.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients&#x02019; EDSS = Median: 1.5 (Range: 0.0&#x02013;4.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T; 3D T1-weighted</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRI analysis <break/>&#x000a0;<break/> Cortical surface reconstruction <break/>&#x000a0;<break/> T1/T2 ratio image reconstruction <break/>&#x000a0;<break/> DTI analysis&#x02014;FA and MD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Median <break/> T2 LV, mL (IQR) = 2.9 (1.3&#x02013;6.3) <break/>&#x000a0;<break/> Median <break/> T1 LV, mL (IQR) = 1.7 (0.7&#x02013;3.8) <break/>&#x000a0;<break/> Median <break/> T2 thalamic LV (normalized for thalamic volume), ml (IQR) = 0.0 (0.0&#x02013;0.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to healthy controls, patients had significantly increased fractional anisotropy in the whole thalamus and increased mean diffusivity in thalamic white matter with a trend toward a reduced thalamic volume. In patients, significant fractional anisotropy abnormalities were detected in bands nearest to CSF and in those closest to white matter, while significant mean diffusivity and T1/T2-weighted ratio abnormalities were found in thalamic bands closest to CSF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacciaguerra, 2024 [<xref rid="B41-pediatrrep-17-00057" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 76 (46 girls); age: (median) 14.8 (7.0&#x02013;17.8). HCs: N = 22 (11 girls); age: 13.8 (8.3&#x02013;17.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.5 (0.0&#x02013;4.0) <break/> Neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3T: T2*-weighted single-shot echo planar imaging <break/> (EPI)-T1W</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resting state</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean = 6.9 SD = 8.5 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PedMS showed reduced RS FC in all networks compared to controls, especially in the basal ganglia. In younger patients, <break/> reduced RS FC in the basal ganglia, language, and sensorimotor networks is associated with poorer cognitive performance. Older patients showed increased RS FC in the basal ganglia, DMN. In both groups, lower RS FC of the caudate nucleus was associated with poorer executive speed</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca, 2009 [<xref rid="B25-pediatrrep-17-00057" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 17 (11 girls); age: 14.6. <break/> HCs: N = 9 (6 girls); age 15.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.0, range 5 0.0&#x02013;3.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5T T2*-W EPI; dual-echo turbo spin echo <break/> sequence (TSE); MPRAGE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Finger tapping + rest</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean = 9.4 &#x000b1; 13.3 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS patients &#x0003e; HCs increased recruitment of the left (L) primary sensorimotor cortex (SMC). They also showed reduced FC between the L primary SMC and the L thalamus, the L insula and the L secondary sensorimotor cortex, the L thalamus and the L insula, and the L thalamus and the L SII</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green, 2018 [<xref rid="B40-pediatrrep-17-00057" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 32; 78% girls; age: 16.28. <break/> HCs: N = 30; 80% girls; age: 16.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = Median: 1.0, range 0.0&#x02013;4.0 <break/> Neuropsychological assessment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">---</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Greater amygdala volume in patients correlated with <break/> parent-reported functional communication and social skills. The right amygdala volume was positively associated with visual memory; the left amygdala volume was a stronger predictor of parent-reported social skills</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waubant, 2009 [<xref rid="B42-pediatrrep-17-00057" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 41 (51.1% girls); age, mean (SD) 11.4 (4.4).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5T/3T; T2-weighted FLAIR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mann- <break/> Whitney <break/>&#x000a0;<break/> Multivariate logistic regression</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Number of T2 LV = 21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediatric MS patients showed significant lesions in the juxtacortical, cerebellar, brainstem, and periventricular areas</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kerbrat, 2012 [<xref rid="B39-pediatrrep-17-00057" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MS: N = 38; (29 girls); age: 15.2. <break/> HCs: N = 33 (28 girls); age: 15.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 T; T1-W <break/> gradient-recalled echo; 2-dimensional multislice proton density-weighted/T2-W fast spin echo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean = 6.3 &#x000b1; 8.1 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The intracranial volume z-score was significantly lower in MS patients compared with the HC participants. Patients with MS also demonstrated significant decreases in normalized brain volume z scores. After correction for global brain volume, thalamic volumes in the MS population remained lower than those of HCs</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rocca, 2010 [<xref rid="B28-pediatrrep-17-00057" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediatric MS: N = 17 (11 girls); age: 14.6. <break/> HCs: N = 10 (6 girls); age 15.8. <break/> Adult patients/Adult HCs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EDSS = 1.0 (0&#x02013;3.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 T; T2*-W single-shot EPI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dynamic causal modeling</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Finger tapping</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean = 9.4 &#x000b1; 13.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The connectivity of the sensorimotor network was similar in control subjects and pediatric MS patients</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Abbreviations</italic>: IQR = interquartile range; FLAIR = fluid attenuated inversion recovery; EDSS = expanded disability status scale; WM = white matter; GM = gray matter; MS = multiple sclerosis; HCs = healthy controls; CI = cognitively impaired; CP = cognitively preserved; RR = relapsing&#x02013;remitting; DIR = double inversion recovery; PSIR = phase-sensitive inversion recovery; DT I = diffusion tensor imaging; FA = fractional anisotropy; MD = mean diffusivity; MRI = magnetic resonance imaging; fMRI = functional magnetic resonance imaging; RS = resting state; FC = functional connectivity; N = number; SD = standard deviation; DMN = default mode network; GLM = general linear model; ANOVA = analysis of variance; T = Tesla; CCPT = conjunctive continuous performance task; CIS = clinically isolated syndrome; NA = not available; EPI = echo planar imaging; FFE = fast field echo; TR = repetition time; TE = time of echo; SE = spin echo; MPRAGE = magnetization-prepared rapid gradient echo.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pediatrrep-17-00057-t004"><object-id pub-id-type="pii">pediatrrep-17-00057-t004_Table 4</object-id><label>Table 4</label><caption><p>Coordinates, ALE, Z, and <italic toggle="yes">p</italic>-values resulting from the ALE meta-analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clusters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hemisphere</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BA</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">x</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Y</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">z</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ALE</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Z</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dorsal anterior cingulate cortex</td><td align="center" valign="middle" rowspan="1" colspan="1">R</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">46</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013638</td><td align="center" valign="middle" rowspan="1" colspan="1">5.568491</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00000</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Supplementary motor cortex</td><td align="center" valign="middle" rowspan="1" colspan="1">L</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005488</td><td align="center" valign="middle" rowspan="1" colspan="1">2.99942</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00135</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Superior parietal Lobe</td><td align="center" valign="middle" rowspan="1" colspan="1">R</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;70</td><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011553</td><td align="center" valign="middle" rowspan="1" colspan="1">5.012381</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00000</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Angular gyrus</td><td align="center" valign="middle" rowspan="1" colspan="1">R</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;58</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">0.010642</td><td align="center" valign="middle" rowspan="1" colspan="1">4.790189</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00000</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Angular gyrus</td><td align="center" valign="middle" rowspan="1" colspan="1">L</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;44</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;72</td><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00792</td><td align="center" valign="middle" rowspan="1" colspan="1">3.794148</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00007</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angular gyrus inferior part</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005742</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.196908</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00069</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Abbreviations</italic>: BA = Brodmann area; ALE = activation likelihood estimation; R = right; L = left.</p></fn></table-wrap-foot></table-wrap></floats-group></article>